These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
|
x
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended December 31, 2018
|
||
|
OR
|
||
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from to
|
||
|
Delaware
(State or Other Jurisdiction of Incorporation or
Organization)
|
|
38-2687639
(IRS Employer Identification No.)
|
|
Title of Each Class:
|
|
Name of Each Exchange on Which Registered:
|
|
Common stock, $0.01 par value
|
|
NASDAQ Stock Market LLC
|
|
Large accelerated filer
x
|
|
Accelerated filer
o
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
|
|
|
|
|
|
|
Emerging growth company
o
|
|
|
|
|
|
|
|
|
|
Page No.
|
|
|
||
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
•
|
Well-Recognized and Established Brands.
We believe each of our go-to-market brands are well-recognized and firmly established in the focused markets we serve. We believe our brands represent high standards and a commitment to quality that our customers rely on when they make their sourcing decisions. In most applications, the products we sell under our brand names meet rigorous industry standards or customer qualifications, providing an advantage over a broad base of competitors. Moreover, we enhance our brand offerings with ongoing investments in new products to help us capture additional customer share and identify new customer or market opportunities.
|
|
•
|
Innovative and Proprietary Manufacturing and Product Technologies.
We believe each of our businesses is well-positioned through years of refined manufacturing know-how, innovative product development and application engineering and solutions design. We believe our manufacturing competencies and installed capital base would be difficult and costly to replicate, providing us an advantage over prospective competitors. We continue to place a priority on investing in innovation to protect and enhance our product designs, brand names and manufacturing methods. TriMas continues to place a priority on driving growth through both product and process innovation within each of its businesses.
|
|
•
|
Customer-Focused Solutions Drive Deep and Long-Term Relationships.
We work collaboratively with our customers to design new product applications that help satisfy rapidly changing preferences in today’s consumer product marketplace. As a recognized leader in many of our markets, customers partner with us during both the product development and production life cycle. These ongoing relationships, often developed over decades, coupled with our expertise in innovation and application engineering, position us to win new and replacement business with our customers when they launch new products or programs. Customers look to TriMas’ businesses for these product innovations because of our long-standing, trusted relationships, which have provided the enabling technologies for their existing products, and our commitment to collaborate on designs for their future products.
|
|
•
|
Well-Established, Extensive Distribution Channels.
Each of our businesses provides products through established distribution channels that cater to the specific needs of our customers’ purchasing preferences. We developed many of these channels over decades, and believe they are a competitive differentiator for us across the markets we serve. In many cases, we provide products directly to our end markets through our locations, while in other cases, we supply to distribution companies that provide our customers with flexible purchasing solutions.
|
|
•
|
TriMas Business Model.
We implemented the TriMas Business Model ("TBM") in late 2016 to improve the management and performance of our businesses. The TBM provides a platform to set near- and long-term performance objectives and goals, including safety, financial, and talent development, measure these against defined objectives, and utilize a reliable communication and escalation process that provides for flexibility and adjustments if market expectations change. We believe the TBM connects our operations, and allows us to benefit from sharing best practices across each of our businesses. We believe that the TBM, through a culture of Kaizen and continuous improvement, helps drive long-term improvement in our performance. For example, since August 2016, we have rationalized 13 manufacturing, warehousing and office locations, streamlined fixed expenses and selling, general and administrative expenses in certain of our businesses, increased our focus on optimizing inventory levels and improved certain of our manufacturing processes. We believe actions driven by the TBM have provided an economic benefit to us and have augmented our cash conversion characteristics and performance overall. Specifically, we reduced our debt from
$374.7 million
at
December 31, 2016
to
$293.6 million
at
December 31, 2018
, and we ended 2018 with
$108.2 million
of cash and cash equivalents on the balance sheet. We will continue to rely on the TBM to drive continuous improvement and to unlock TriMas’ value potential.
|
|
•
|
Leverage The TriMas Business Model to Drive Performance.
A key tenet of the TBM is our commitment to operational excellence and continuous improvement. We adopted the use of Kaizen methodology within our operations, which is predicated on engaging our employees, to improve all aspects of our businesses. We believe our operating performance will continue to benefit from the use of Kaizen as a means to drive our decision-making processes. In addition to continuous improvement, the TBM is also focused on environmental, health and safety, annual goal setting and measurement, flawless launches, and talent development.
|
|
•
|
Enhance Long-term Growth through Innovation.
Each of our businesses sells products under well-recognized brand names in the focused markets they serve. We intend to leverage our brands, expand our product offerings to current and new customers, and introduce innovative products to meet our customers' needs and help solve their challenges. We believe this disciplined approach will allow us to defend and expand our product offerings and grow our business over the longer term. In addition to product innovation, we also value process innovation and believe we can solidify our customer relationships as innovative new processes and manufacturing "know-how" allow us to improve our quality, speed to market and overall competitiveness, increasing customer satisfaction, as well as our performance.
|
|
•
|
Operate in a Culture Committed to Cash Conversion.
We use the TBM to drive management’s decision-making processes to achieve our annual growth and profitability targets, as well as drive our businesses towards achieving market-leading returns and cash flow conversion. We believe our commitment to having well-defined strategies in place, setting and executing against annual goals and long-range targets, operating in a data-driven environment, and awarding our team on annual cash flow achievement will allow us to invest in and grow our businesses.
|
|
•
|
Utilize a Disciplined Approach to Capital Allocation.
We believe we have the ability to generate substantial free cash flow for reinvestment in our businesses consistent with our capital allocation priorities. We will continue to execute our disciplined approach to capital allocation and other investments. We will invest in organic growth in our most compelling market segments with the highest return potential, and manage indebtedness consistent with our long-term net leverage target. We will also consider strategic bolt-on acquisitions, as well as other capital allocation actions consistent with our long-term, financial goals, such as repurchasing shares of our outstanding common stock.
|
|
•
|
Strong Product Innovation
. We believe that Rieke’s product development capability is a competitive advantage. Through its Global Innovation Centers located in the United States, United Kingdom and India, Rieke is focused on driving innovation across a broad range of dispensing and closure solutions for its customers. Rieke’s product development programs have provided innovative and proprietary product solutions, such as the Visegrip
®
steel flange and plug closure, and the all-plastic, environmentally safe, self-venting FlexSpout
®
flexible pouring spout. Rieke, partnering with Amazon, also developed a range of products designed to meet the requirements of the high-growth e-commerce retail channel, including a proprietary dispenser locking mechanism to protect the integrity of packages and prevent liquids from leaking during shipment. As a result of this innovation, Rieke was honored as a Diamond Finalist for Packaging Innovation by Dow Chemical in 2018 for the development of a new lotion dispensing pump for e-commerce solutions. Other developments include a measured-dose dispenser that provides exact doses of highly-concentrated liquids for the health and beauty market. Rieke’s emphasis on highly-engineered solutions and product development has yielded numerous issued and enforceable patents, with many other patent applications pending.
|
|
•
|
Customized Solutions that Enhance Customer Loyalty and Relationships
. A significant portion of Rieke’s products are customized designs that are developed and engineered to address specific customer technical, marketing and sustainability needs, helping to distinguish our customers’ products from that of their competitors. For example, the customization of specialty plastic caps and closures including branding, unique colors, collar sizes, lining and venting results in substantial customer loyalty. The substantial investment in flexible manufacturing cells allows Rieke to offer both short lead-times for high volume products and extensive customization for low order volumes, which provides significant advantages to our consumer packaged goods customer base. In addition, Rieke provides customized dispensing solutions including unique pump designs, precision metering, unique colors and special collar sizes to fit the customer’s bottles. Rieke has also been successful in promoting the sale of complementary products in an effort to achieve preferred supplier status with several customers.
|
|
•
|
Leading Market Positions and Global Presence.
Rieke maintains a global network of manufacturing and distribution sites, to serve our increasingly global customer base. Rieke’s global customers often desire supply chain capability and a flexible manufacturing footprint close to their end markets which result in shorter supply chains, reduced carbon footprint and better sustainability. To serve our customers in Asia, we have design and manufacturing capacity and offer highly engineered dispensing solutions through locations in China, India and Vietnam, and increased our Asian market sales coverage. Additionally, Rieke opened a facility in San Miguel de Allende, Mexico during 2017, to replace an older facility in Mexico City, and provide additional manufacturing capacity to support growth. This flexible manufacturing footprint provides Rieke with multiple alternatives for production to best meet customer requirements and mitigate the impacts of potential trade disruption. The majority of Rieke’s manufacturing facilities around the world have advanced injection molding machines required to manufacture precision engineered dispensing and closure components, as well as automated, high-speed assembly equipment for multi-component products.
|
|
•
|
Innovate New Products and New Applications.
Rieke has focused product development capabilities on consumer applications requiring special packaging forms, stylized containers and dispensing systems requiring a high degree of functionality and engineering, as well as evolving its industrial applications to include child resistant closures and other applications. Rieke has a consistent pipeline of new products ready for launch. For example, 52 patents were filed and 25 patents were issued in
2018
. Being a leader in e-commerce packaging allows Rieke to collaborate with Amazon, resulting in innovative solutions, including the E-Commerce Trigger Sprayer, that meets consumers' demands and meets ISTA 6 standards as required by Amazon.
|
|
•
|
Increase Global Presence.
Rieke successfully globalizes its products by customizing products to meet regional market requirements. Our global network of manufacturing and distribution sites ensures customers have a global product standard manufactured locally resulting in reduced order lead-times and product support where our customers require. We believe Rieke is able to offer a wider variety of products to our global customers with enhanced service support and has entered into supply agreements with many of these customers based on our broad product offering. Over the past few years, Rieke has increased its global manufacturing and sales presence, with advanced manufacturing capabilities in China, India, Vietnam and Mexico. We have also increased our sales coverage in Europe and Asia, and in January 2019, closed on the acquisition of Plastic Srl, a manufacturer of polymeric caps and closures for home care product applications, located in Forlì, Italy, which provides us with additional manufacturing capacity and sales presence in Europe. By maintaining a presence in international locations, Rieke focuses on developing new markets and new applications for its products, capitalizing on its global design and manufacturing capabilities.
|
|
•
|
Leverage The TriMas Business Model to Drive Performance.
Rieke is committed to operational excellence and continuous improvement and has utilized the Kaizen methodology within its operations. For example, Rieke is continuously evaluating its floor plans and flow to maximize the efficiency and cost of the manufacturing and assembly processes. Rieke also works diligently to effectively use it materials and to eliminate as much scrap as possible in the manufacturing process. In addition to continuous improvement, Rieke is focused on quality and safety of its products and processes.
|
|
•
|
Monogram Aerospace Fasteners (“Monogram”).
The product offering includes permanent threaded blind bolts, including high-strength, rotary-actuated blind bolts that allow sections of aircraft to be joined together when access is limited to only one side of the airframe, providing cost efficiencies over conventional two piece fastening devices. Monogram also provides collars and temporary fasteners used in aircraft construction and assembly.
|
|
•
|
Allfast Fastening Systems (“Allfast”).
The product offering includes solid and blind rivets, blind bolts, temporary fasteners and installation tools for the aerospace industry.
|
|
•
|
Mac Fasteners.
The product offering consists of high-volume, standard aerospace screws and bolts, including NAS, MS, AN and AS standards.
|
|
•
|
Martinic Engineering.
The product offering includes highly-engineered, precision machined, complex machine-to-print parts for aerospace applications, including auxiliary power units, as well as electrical, hydraulic and pneumatic systems. Effective in the first quarter of 2019, Martinic Engineering will be reported within the Specialty Products segment.
|
|
•
|
Broad Product Portfolio of Established Brands
. We believe that TriMas Aerospace is a leading designer and manufacturer of fasteners and other complex, precision-machined components for the aerospace industry. The combination of the Monogram, Allfast and Mac Fasteners brands enables TriMas Aerospace to offer a wide range of fastener products which address a broad scope of customer requirements, providing scale to customers who continue to rationalize their supply base. In several of the product categories, including rotary-actuated blind bolts and blind and solid rivets, TriMas Aerospace has a meaningful market share with well-known and established brands.
|
|
•
|
Product Innovation.
We believe that TriMas Aerospace’s engineering, research and development capability and new product focus are competitive advantages. For many years, TriMas Aerospace’s product development programs have provided innovative and proprietary product solutions. We believe our customer-focused approach to provide cost-effective technical solutions will drive the development of new products and create new opportunities for growth. Our innovation team adds value by working directly with our customers to address assembly and manufacturing process challenges to increase productivity, quality, speed and efficiency, while reducing overall installed cost.
|
|
•
|
Leading Manufacturing Capabilities and Processes.
We believe that TriMas Aerospace is a leading manufacturer of precision engineered components for the aerospace industry. Given industry regulatory requirements, as well as customer requirements, it is required that these products need to be manufactured within tight tolerances and specifications, often out of hard-to-work-with materials including titanium, inconel and specialty steels. Many of TriMas Aerospace’s products, facilities and manufacturing processes are required to be qualified and/or certified. Key certifications in TriMas Aerospace include: AS9100:2009 Revision D; ISO9001:2008; TSO; and NADCAP for non-destructive testing, heat treatment, wet processes and materials testing. While proprietary products and patents are important, having proprietary manufacturing processes and capabilities makes TriMas Aerospace’s products difficult to replicate. We believe TriMas Aerospace’s manufacturing processes, capabilities and quality focus create a competitive strength for the business.
|
|
•
|
Develop, Qualify and Commercialize Innovative Fastener Products
. TriMas Aerospace has a history of successfully developing and introducing new products and there are currently several new product initiatives underway. We focus on expanding our current products into new applications on the aircraft, as well as securing qualified products onto new programs. TriMas Aerospace products contain patent protection, with additional patents pending, and are manufactured using proprietary manufacturing processes and “know-how.” TriMas Aerospace has developed new fastener products that offer a flush break upon installation and is developing and testing other fastener designs which offer improved clamping characteristics on composite structures. An example of such would include the newer Composi-Lite™ fastener, affording significant installed weight savings in concert with fuel efficient aircraft designs. TriMas Aerospace has also recently designed the next generation temporary fastener with an 800% increase in clamping force called Fastack® SC (Super Clamp). TriMas Aerospace has also expanded its fastener offerings to include other fastening product applications on current aircraft, including the expansion of its suite of collar families used in traditional two-sided assembly. The close working relationship between our sales and engineering teams and our customers’ engineering teams is key to developing future products desired and required by our customers.
|
|
•
|
Leverage the TriMas Business Model
. TriMas Aerospace is focused on continuously improving its processes and manufacturing operations by using the tools of Kaizen and automation, as applicable. The aerospace industry has strict requirements for quality and delivery, making process innovation and continuous improvement vital to TriMas Aerospace's success. In addition, the combined product sets of the Monogram, Allfast and Mac Fasteners brands uniquely position us to benefit from platform-wide supply opportunities. In addition, our aerospace platform should benefit from leveraging combined purchasing activities and other back-office functions, joint commercial and product development efforts, and sharing of best practices among previously separate businesses. TriMas Aerospace customers benefit from a combined product portfolio of proprietary products and product development efforts. As a result of these strong customer relationships and operational excellence in 2018, TriMas Aerospace has been recognized by our customers, including receipt of the Boeing Performance Excellence Award for the seventh year in a row and the 2018 Best Performer Award from Airbus.
|
|
•
|
Norris Cylinder
. We believe Norris Cylinder is a leading designer, manufacturer and distributor of highly-engineered steel cylinders for use in industrial, construction, health care and defense end markets. We believe that Norris Cylinder is a leading provider of a complete line of large, intermediate and small size, high and low-pressure steel cylinders for the transportation, storage and dispensing of compressed gases. Norris Cylinder’s large high-pressure seamless gas cylinders are used principally for shipping, storing and dispensing oxygen, nitrogen, argon, helium and other compressed gases. In addition, Norris Cylinder offers a complete line of steel cylinders used to contain and dispense acetylene gas for the welding and cutting industries. Norris Cylinder's products meet the rigorous standards required by the Department of Transportation ("DOT") or International Standards Organization ("ISO"), which certifies a cylinder's adequacy to perform in specific applications. Norris Cylinder markets cylinders primarily to domestic and international industrial gas producers and distributors, welding equipment distributors and equipment manufacturers. Given this customer base, Norris Cylinder tends to grow in times of increased industrial and infrastructure investment.
|
|
•
|
Lamons.
We believe Lamons is a leading designer, manufacturer and distributor of industrial sealing, fastener and specialty products for the petrochemical, petroleum refining, oil field, water/waste water treatment and other industrial markets. These products are used in recurring MRO activities, as well as in the construction of new facilities or capacity expansions for industrial OEMs. Our sealing and fastener solutions typically represent a low-cost element of an overall project spend, but many times are needed with quick-turn capabilities to minimize our customers' facility down-time, as well as operate in harsh conditions with severe consequences of failure. As a result, we believe customers often choose to work with Lamons, given its long-standing, reputable brand name known for quality products and expedited customer service.
|
|
•
|
Arrow Engine
. We believe that Arrow Engine is a leading provider of natural gas powered wellhead engines, compressors and replacement parts, all engineered for use in oil and natural gas production and other industrial and commercial markets. As Arrow's engines can operate from the natural gas produced at the wellhead, we believe Arrow is uniquely positioned to provide its products for remote pump jack installations. Arrow Engine distributes its products through a worldwide distribution network with a particularly strong presence in the United States and Canada. Arrow Engine manufactures its own engine line and also offers a wide variety of spare parts for various industrial engines not manufactured by Arrow Engine, including selected engines manufactured and sold under the Caterpillar
®
, Waukesha
®
and Ajax
®
brands. Arrow Engine has expanded its product line to include compressors and compressor packaging, as well as certain gas production equipment.
|
|
•
|
Leading Market Positions and Strong Brand Names
. Norris Cylinder, with more than 70 years of experience, is one of the worlds' largest manufacturers of high- and low-pressure steel cylinders, and the only manufacturer in the United States. We believe that Norris has a reputation for high-quality cylinders used in a variety of applications, including industrial gas, welding and cutting, government, medical, laboratories, food and beverage technology, breathing air, fire protection and aviation. We also believe Lamons is one of the largest gasket and bolt suppliers to the U.S. energy market. We believe that Lamons is known as a quality brand and offers premium service to the industry. We also believe that our facilities have the latest proprietary technology and equipment to be able to produce urgent requirement gaskets and bolts locally to meet our customers’ demands. We believe that Arrow Engine has also built a reputation for quality equipment, parts and accessories used in oil and natural gas production, and has a leading market position in the niche it serves.
|
|
•
|
Comprehensive Product Offering
. Norris Cylinder offers a complete line of large, intermediate and small size, high and low-pressure steel cylinders to its customers across a variety of end markets. Lamons offers a full suite of custom and standard metallic and nonmetallic gasket and bolt products to the petroleum refining, petrochemical, oil field and industrial markets. Over the years, Lamons expanded its product offering to include custom-manufactured, specialty bolts of various sizes, other CNC-machined components and isolation gasket kits. Arrow Engine also provides a comprehensive product offering, including engines, compressors, chemical pumps, generator sets, electronics and replacement parts to a variety of oilfield and industrial markets.
|
|
•
|
Established and Extensive Distribution Channels
. Lamons utilizes an established hub-and-spoke distribution system whereby our primary manufacturing facility supplies products to our own branches and a highly knowledgeable network of worldwide distributors and licensees, which are located in close proximity to our primary customers. Enabled by its branch network and close proximity to its customers, Lamons' ability to provide quick turn-around and customized solutions for its customers provides a competitive advantage. Norris Cylinder has long-standing customer relationships and distributes directly to major gas companies, as well as distributing to domestic buying groups, OEMs, medium and small independent gas companies, and independent gas and welding distributors.
|
|
•
|
Leverage The TriMas Business Model to Drive Performance.
Over the past couple of years, we reduced our cost structure through ongoing manufacturing, overhead and administrative productivity initiatives, and global sourcing of certain components. At Lamons and Arrow Engine, we performed a comprehensive review of our physical footprint and have closed or consolidated locations to reduce and realign our fixed cost structure to current market demand levels. We have also reconfigured our facilities to increase efficiency and reduce our operating cost structure, allowing for incremental capacity. Norris Cylinder has deployed previously acquired assets to mitigate risk, improve efficiency and support its future expected growth, increasing its manufacturing flexibility for both large and small high pressure cylinders. We have also variablized Arrow Engine's cost structure to respond quickly to end market changes and enhance flexibility, driving low cost sourcing efforts, and focusing on additional productivity and Lean initiatives. We are also working to mitigate material cost increases and indirect impacts of tariffs through commercial negotiations, sourcing actions, leveraging existing footprint and cost savings initiatives. We believe that there are also additional opportunities to improve our operational efficiency through continued implementation of Lean-based manufacturing initiatives. Through the methods of Kanban and improved production planning, inventory management and order fulfillment processes, we believe Lamons can improve its margins, while reducing product lead-times and increasing customer fill-rates.
|
|
•
|
Expand Offering and Markets.
Norris Cylinder has been pursuing new end markets such as cylinders for use as hydrogen fuel cells in storage (cell towers), transport (fork trucks), breathing air applications and in fire suppression. Norris Cylinder has also created new designs for seamless acetylene applications in marine and international markets. Over the past few years, we have also launched several new highly-engineered and specialty products and have broadened our specialty bolt offering at Lamons. Examples of new products include: WRI-LP gaskets, a hydrofluoric acid gasket solution; inhibitor gaskets designed to prevent corrosion in offshore platform flanges; IsoTek
TM
Gaskets, an engineered sealing solution for flanged pipe connections; hose products; and intelligent bolts, which provide more reliable load indication. Arrow Engine continues to expand its product portfolio to serve new customers and new applications for oil and natural gas production in all areas of the industry, including shale drilling. Arrow Engine has also launched an offering of customizable compressors and gas production equipment, which are used by existing end customers in the oil and natural gas extraction markets, as well as developed a natural gas compressor used for compressed natural gas filling stations. Although tempered by lower drilling levels over the past few years, Arrow Engine has also been focused on expanding its international sales, particularly in Mexico.
|
|
•
|
should our leverage increase, it may place us at a competitive disadvantage as compared with our less leveraged competitors and make us more vulnerable in the event of a downturn in general economic conditions or in any of our businesses;
|
|
•
|
our flexibility in planning for, or reacting to, changes in our businesses and the industries in which we operate may be limited;
|
|
•
|
a substantial portion of our cash flow from operations will be dedicated to the payment of annual interest and future principal obligations on our indebtedness, thereby reducing the funds available to us for operations, capital expenditures, acquisitions, future business opportunities or obligations to pay rent in respect of our operating leases; and
|
|
•
|
our operations are restricted by our debt instruments, which contain certain financial and operating covenants, and those restrictions may limit, among other things, our ability to borrow money in the future for working capital, capital expenditures, acquisitions, rent expense or other purposes.
|
|
•
|
pay dividends or redeem or repurchase capital stock;
|
|
•
|
incur additional indebtedness and grant liens;
|
|
•
|
make acquisitions and joint venture investments; and
|
|
•
|
sell assets.
|
|
•
|
volatility of currency exchange between the U.S. dollar and currencies in international markets;
|
|
•
|
changes in local government regulations and policies including, but not limited to, foreign currency exchange controls or monetary policy, governmental embargoes, repatriation of earnings, expropriation of property, duty or tariff restrictions, investment limitations and tax policies;
|
|
•
|
political and economic instability and disruptions, including labor unrest, civil strife, acts of war, guerrilla activities, insurrection and terrorism;
|
|
•
|
legislation that regulates the use of chemicals;
|
|
•
|
disadvantages of competing against companies from countries that are not subject to U.S. laws and regulations, including the Foreign Corrupt Practices Act ("FCPA");
|
|
•
|
compliance with international trade laws and regulations, including export control and economic sanctions, such as anti-dumping duties;
|
|
•
|
difficulties in staffing and managing multi-national operations;
|
|
•
|
limitations on our ability to enforce legal rights and remedies;
|
|
•
|
tax inefficiencies in repatriating cash flow from non-U.S. subsidiaries that could affect our financial results and reduce our ability to service debt;
|
|
•
|
reduced protection of intellectual property rights; and
|
|
•
|
other risks arising out of foreign sovereignty over the areas where our operations are conducted.
|
|
|
|
|
Packaging
|
|
Aerospace
|
|
Specialty Products
|
|
United States:
|
|
|
|
|
|
|
|
|
|
Alabama
|
|
|
|
|
|
Huntsville
|
|
|
Arkansas
|
|
Atkins
(1)
|
|
|
|
|
|
|
Arizona
|
|
|
|
Tempe
(1)
Tolleson |
|
|
|
|
California
|
|
Irwindale
(1)
Rohnert Park (1) |
|
City of Industry
Commerce (1)
Stanton
(1)
|
|
|
|
|
Indiana
|
|
Auburn
Hamilton (1) |
|
|
|
|
|
|
Kansas
|
|
|
|
Ottawa
|
|
|
|
|
Ohio
|
|
New Albany
(1)
|
|
|
|
|
|
|
Oklahoma
|
|
|
|
|
|
Tulsa
|
|
|
Texas
|
|
|
|
|
|
Houston
(1)
Longview |
|
|
|
|
|
|
|
|
|
|
International:
|
|
|
|
|
|
|
|
|
|
Belgium
|
|
|
|
|
|
Geel, Antwerp
(1)
|
|
|
Canada
|
|
|
|
|
|
Sarnia, Ontario
(1)
|
|
|
China
|
|
Haining City
(1)
Hangzhou
(1)
|
|
|
|
|
|
|
Germany
|
|
Neunkirchen
|
|
|
|
|
|
|
India
|
|
Baddi
New Delhi
(1)
|
|
|
|
|
|
|
Mexico
|
|
San Miguel de Allende
(1)
|
|
|
|
|
|
|
Singapore
|
|
|
|
|
|
Singapore
(1)
|
|
|
Thailand
|
|
|
|
|
|
Muang Rayong
(1)
|
|
|
United Kingdom
|
|
Leicester
|
|
|
|
|
|
|
Vietnam
|
|
Thu Dau Mot
(1)
|
|
|
|
|
|
(1)
|
Represents a leased facility. All such leases are operating leases.
|
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
(1)
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
(1)
|
||||||
|
October 1, 2018 to October 31, 2018
|
|
112,036
|
|
|
$
|
27.76
|
|
|
112,036
|
|
|
$
|
43,298,871
|
|
|
November 1, 2018 to November 30, 2018
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
43,298,871
|
|
|
December 1, 2018 to December 31, 2018
|
|
206,458
|
|
|
$
|
26.39
|
|
|
206,458
|
|
|
$
|
37,851,045
|
|
|
Total
|
|
318,494
|
|
|
$
|
26.87
|
|
|
318,494
|
|
|
$
|
37,851,045
|
|
|
(1)
|
Pursuant to a publicly announced share repurchase program from November 2015, during the three months ended
December 31, 2018
, the Company repurchased
318,494
shares of its common stock at a cost of approximately
$8.6 million
. The share repurchase program, pursuant to which the Company is authorized to purchase up to
$50 million
in aggregate of its common stock, is effective and has no expiration date. On February 28, 2019, the Company announced that its Board of Directors increased the Company’s common stock share repurchase authorization to
$75 million
in the aggregate. The increased authorization includes the value of shares already purchased under the previous authorization.
|
|
|
|
Year ended December 31,
|
||||||||||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net sales
|
|
$
|
877,140
|
|
|
$
|
817,740
|
|
|
$
|
794,020
|
|
|
$
|
863,980
|
|
|
$
|
887,300
|
|
|
Gross profit
|
|
244,120
|
|
|
219,390
|
|
|
210,800
|
|
|
236,430
|
|
|
237,250
|
|
|||||
|
Operating profit (loss)
(a)
|
|
122,070
|
|
|
89,170
|
|
|
(41,930
|
)
|
|
(3,170
|
)
|
|
87,460
|
|
|||||
|
Income (loss) from continuing operations
(a)
|
|
83,300
|
|
|
30,960
|
|
|
(39,800
|
)
|
|
(28,660
|
)
|
|
46,890
|
|
|||||
|
Per Share Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Continuing operations
(a)
|
|
$
|
1.82
|
|
|
$
|
0.68
|
|
|
$
|
(0.88
|
)
|
|
$
|
(0.64
|
)
|
|
$
|
1.03
|
|
|
Weighted average shares
|
|
45,825
|
|
|
45,683
|
|
|
45,407
|
|
|
45,124
|
|
|
44,882
|
|
|||||
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Continuing operations
(a)
|
|
$
|
1.80
|
|
|
$
|
0.67
|
|
|
$
|
(0.88
|
)
|
|
$
|
(0.64
|
)
|
|
$
|
1.02
|
|
|
Weighted average shares
|
|
46,170
|
|
|
45,990
|
|
|
45,407
|
|
|
45,124
|
|
|
45,269
|
|
|||||
|
|
|
Year ended December 31,
|
||||||||||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Total assets
(b)
|
|
$
|
1,100,520
|
|
|
$
|
1,033,200
|
|
|
$
|
1,051,650
|
|
|
$
|
1,170,300
|
|
|
$
|
1,625,430
|
|
|
Total debt
(b)
|
|
293,560
|
|
|
303,080
|
|
|
374,650
|
|
|
419,630
|
|
|
630,810
|
|
|||||
|
Goodwill and other intangibles
(a)
|
|
491,180
|
|
|
513,610
|
|
|
529,000
|
|
|
652,790
|
|
|
757,500
|
|
|||||
|
(a)
|
During 2016 and 2015, we recorded goodwill and indefinite-lived intangible asset impairment charges totaling approximately
$98.9 million
and
$75.7 million
, respectively. See Note
6
, "
Goodwill and Other Intangibles Assets,
" included in Item 8, "
Financial Statements and Supplementary Data
," within this Form 10-K for further information.
|
|
(b)
|
During 2015, we completed the spin-off of our Cequent businesses, thereby reducing the amount of our total assets and total debt as compared to prior periods. Total assets at December 31, 2014 include approximately $333.3 million of assets related to our Cequent businesses.
|
|
|
|
Year ended December 31,
|
|||||||||||||||||||
|
|
|
2018
|
|
As a Percentage of Net Sales
|
|
2017
|
|
As a Percentage of Net Sales
|
|
2016
|
|
As a Percentage of Net Sales
|
|||||||||
|
Net Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Packaging
|
|
$
|
368,200
|
|
|
42.0
|
%
|
|
$
|
344,570
|
|
|
42.1
|
%
|
|
$
|
341,340
|
|
|
43.0
|
%
|
|
Aerospace
|
|
185,920
|
|
|
21.2
|
%
|
|
184,310
|
|
|
22.6
|
%
|
|
174,920
|
|
|
22.0
|
%
|
|||
|
Specialty Products
|
|
323,020
|
|
|
36.8
|
%
|
|
288,860
|
|
|
35.3
|
%
|
|
277,760
|
|
|
35.0
|
%
|
|||
|
Total
|
|
$
|
877,140
|
|
|
100.0
|
%
|
|
$
|
817,740
|
|
|
100.0
|
%
|
|
$
|
794,020
|
|
|
100.0
|
%
|
|
Gross Profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Packaging
|
|
$
|
119,620
|
|
|
32.5
|
%
|
|
$
|
116,620
|
|
|
33.8
|
%
|
|
$
|
121,030
|
|
|
35.5
|
%
|
|
Aerospace
|
|
49,630
|
|
|
26.7
|
%
|
|
48,910
|
|
|
26.5
|
%
|
|
35,660
|
|
|
20.4
|
%
|
|||
|
Specialty Products
|
|
74,870
|
|
|
23.2
|
%
|
|
53,860
|
|
|
18.6
|
%
|
|
54,110
|
|
|
19.5
|
%
|
|||
|
Total
|
|
$
|
244,120
|
|
|
27.8
|
%
|
|
$
|
219,390
|
|
|
26.8
|
%
|
|
$
|
210,800
|
|
|
26.5
|
%
|
|
Selling, General and Administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Packaging
|
|
$
|
35,030
|
|
|
9.5
|
%
|
|
$
|
38,310
|
|
|
11.1
|
%
|
|
$
|
42,030
|
|
|
12.3
|
%
|
|
Aerospace
|
|
22,340
|
|
|
12.0
|
%
|
|
22,370
|
|
|
12.1
|
%
|
|
27,170
|
|
|
15.5
|
%
|
|||
|
Specialty Products
|
|
40,360
|
|
|
12.5
|
%
|
|
36,910
|
|
|
12.8
|
%
|
|
49,850
|
|
|
17.9
|
%
|
|||
|
Corporate expenses
|
|
24,070
|
|
|
N/A
|
|
|
31,550
|
|
|
N/A
|
|
|
32,910
|
|
|
N/A
|
|
|||
|
Total
|
|
$
|
121,800
|
|
|
13.9
|
%
|
|
$
|
129,140
|
|
|
15.8
|
%
|
|
$
|
151,960
|
|
|
19.1
|
%
|
|
Operating Profit (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Packaging
|
|
$
|
84,590
|
|
|
23.0
|
%
|
|
$
|
80,610
|
|
|
23.4
|
%
|
|
$
|
78,630
|
|
|
23.0
|
%
|
|
Aerospace
|
|
27,290
|
|
|
14.7
|
%
|
|
26,410
|
|
|
14.3
|
%
|
|
(90,540
|
)
|
|
(51.8
|
)%
|
|||
|
Specialty Products
|
|
34,260
|
|
|
10.6
|
%
|
|
12,280
|
|
|
4.3
|
%
|
|
2,900
|
|
|
1.0
|
%
|
|||
|
Corporate
|
|
(24,070
|
)
|
|
N/A
|
|
|
(30,130
|
)
|
|
N/A
|
|
|
(32,920
|
)
|
|
N/A
|
|
|||
|
Total
|
|
$
|
122,070
|
|
|
13.9
|
%
|
|
$
|
89,170
|
|
|
10.9
|
%
|
|
$
|
(41,930
|
)
|
|
(5.3
|
)%
|
|
Capital Expenditures
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Packaging
|
|
$
|
13,590
|
|
|
3.7
|
%
|
|
$
|
17,140
|
|
|
5.0
|
%
|
|
$
|
19,880
|
|
|
5.8
|
%
|
|
Aerospace
|
|
1,190
|
|
|
0.6
|
%
|
|
3,370
|
|
|
1.8
|
%
|
|
3,950
|
|
|
2.3
|
%
|
|||
|
Specialty Products
|
|
5,380
|
|
|
1.7
|
%
|
|
6,830
|
|
|
2.4
|
%
|
|
7,470
|
|
|
2.7
|
%
|
|||
|
Corporate
(a)
|
|
4,890
|
|
|
N/A
|
|
|
9,460
|
|
|
N/A
|
|
|
30
|
|
|
N/A
|
|
|||
|
Total
|
|
$
|
25,050
|
|
|
2.9
|
%
|
|
$
|
36,800
|
|
|
4.5
|
%
|
|
$
|
31,330
|
|
|
3.9
|
%
|
|
Depreciation
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Packaging
|
|
$
|
12,510
|
|
|
3.4
|
%
|
|
$
|
12,240
|
|
|
3.6
|
%
|
|
$
|
12,390
|
|
|
3.6
|
%
|
|
Aerospace
|
|
6,570
|
|
|
3.5
|
%
|
|
5,900
|
|
|
3.2
|
%
|
|
5,460
|
|
|
3.1
|
%
|
|||
|
Specialty Products
|
|
5,220
|
|
|
1.6
|
%
|
|
8,630
|
|
|
3.0
|
%
|
|
6,260
|
|
|
2.3
|
%
|
|||
|
Corporate
|
|
280
|
|
|
N/A
|
|
|
180
|
|
|
N/A
|
|
|
280
|
|
|
N/A
|
|
|||
|
Total
|
|
$
|
24,580
|
|
|
2.8
|
%
|
|
$
|
26,950
|
|
|
3.3
|
%
|
|
$
|
24,390
|
|
|
3.1
|
%
|
|
Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Packaging
|
|
$
|
9,110
|
|
|
2.5
|
%
|
|
$
|
9,390
|
|
|
2.7
|
%
|
|
$
|
9,730
|
|
|
2.9
|
%
|
|
Aerospace
|
|
8,620
|
|
|
4.6
|
%
|
|
8,630
|
|
|
4.7
|
%
|
|
8,630
|
|
|
4.9
|
%
|
|||
|
Specialty Products
|
|
1,710
|
|
|
0.5
|
%
|
|
1,900
|
|
|
0.7
|
%
|
|
2,110
|
|
|
0.8
|
%
|
|||
|
Corporate
|
|
—
|
|
|
N/A
|
|
|
—
|
|
|
N/A
|
|
|
—
|
|
|
N/A
|
|
|||
|
Total
|
|
$
|
19,440
|
|
|
2.2
|
%
|
|
$
|
19,920
|
|
|
2.4
|
%
|
|
$
|
20,470
|
|
|
2.6
|
%
|
|
•
|
increased sales levels across our end markets, primarily driven by higher demand for our industrial and oil and gas-related products within our Specialty Products reportable segment and from growth in our health, beauty and home care end market within our Packaging reportable segment;
|
|
•
|
benefits of leveraging the TBM, as we continue to drive operating improvements, as well as evaluate, realign and streamline fixed costs and selling, general and administrative expenses;
|
|
•
|
the impact of the Tax Reform Act, contributing to a lower overall effective tax rate;
|
|
•
|
higher commodity costs, primarily related to oil and steel-based raw materials, primarily impacting our Packaging reportable segment;
|
|
•
|
the termination of the liability to Metaldyne, resulting in an approximate $8.2 million reduction in selling, general and administrative expenses; and
|
|
•
|
the impact of fees and expenses related to our issuance of Senior Notes and other refinancing activities in 2017.
|
|
|
|
Year ended December 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Corporate operating expenses
|
|
$
|
22.3
|
|
|
$
|
20.9
|
|
|
Non-cash stock compensation
|
|
7.2
|
|
|
6.8
|
|
||
|
Legacy (income) expenses, net
|
|
(5.4
|
)
|
|
2.4
|
|
||
|
Corporate expenses
|
|
$
|
24.1
|
|
|
$
|
30.1
|
|
|
•
|
the impact of improved throughput and productivity in our Aerospace reportable segment, enabling this segment to achieve higher sales and profit levels in 2017;
|
|
•
|
the continued benefits of the realigned footprint within our Specialty Products reportable segment, with lower ongoing operating costs following several facility consolidations and closures;
|
|
•
|
the impact of Hurricane Harvey, primarily within our Specialty Products reportable segment;
|
|
•
|
the impact of fees and expenses related to our issuance of Senior Notes and other refinancing activities in 2017;
|
|
•
|
the impact of the Tax Reform Act, primarily impacting our 2017 income tax expense; and
|
|
•
|
approximately $98.9 million goodwill and intangible asset impairment charges in 2016 in our Aerospace reportable segment.
|
|
|
|
Year ended December 31,
|
||||||
|
|
|
2017
|
|
2016
|
||||
|
Corporate operating expenses
|
|
$
|
20.9
|
|
|
$
|
23.9
|
|
|
Non-cash stock compensation
|
|
6.8
|
|
|
6.9
|
|
||
|
Legacy expenses
|
|
2.4
|
|
|
2.1
|
|
||
|
Corporate expenses
|
|
$
|
30.1
|
|
|
$
|
32.9
|
|
|
•
|
In
2018
, the Company generated
$146.0 million
in cash flows, based on the reported net income of
$83.3 million
and after considering the effects of non-cash items related to losses on dispositions of businesses and other assets, depreciation, amortization, changes in deferred income taxes, debt financing and related expenses, stock-based compensation and other operating activities. In
2017
, the Company generated
$111.2 million
in cash flows based on the reported net income of
$31.0 million
and after considering the effects of similar non-cash items.
|
|
•
|
Increases in accounts receivable resulted in a use of cash of approximately
$11.4 million
in
2018
, primarily due to the increase in sales levels and the timing of sales and collection of cash. Decreases in accounts receivable resulted in a source of cash of approximately
$1.2 million
in
2017
. Days sales outstanding of receivables remained flat year-over-year.
|
|
•
|
We increased our investment in inventory by approximately
$18.7 million
in 2018 to support the increased sales levels, nearly $8.0 million of which occurred in the fourth quarter as we received foreign-sourced goods ahead of the expected increase in tariff rates. We reduced our investment in inventory by approximately
$4.4 million
in
2017
, primarily due to our facility consolidation efforts. Our days sales in inventory increased by five days in
2018
as compared to
2017
, primarily as a result of the fourth quarter 2018 increase.
|
|
•
|
Decreases in prepaid expenses and other assets resulted in a source of cash of approximately
$9.1 million
in
2018
, primarily as a result of the timing of payments made for income taxes and certain operating expenses. Increases in prepaid expenses and other assets resulted in a use of cash of approximately
$0.3 million
in
2017
.
|
|
•
|
Increases in accounts payable and accrued liabilities resulted in a source of cash of approximately
$4.3 million
and
$3.6 million
in
2018
and
2017
, respectively, primarily a result of higher purchases of inventory and other supplies to support higher sales demand. Our days accounts payable on hand increased by 10 days year-over-year, primarily due to the mix of payment terms in December 2018, which increased given longer payment terms to certain foreign vendors.
|
|
|
|
Year ended
December 31, 2018 |
||
|
Net income
|
|
$
|
83,300
|
|
|
Bank stipulated adjustments:
|
|
|
||
|
Interest expense, net (as defined)
|
|
13,910
|
|
|
|
Income tax expense
|
|
20,950
|
|
|
|
Depreciation and amortization
|
|
44,020
|
|
|
|
Non-cash compensation expense
(1)
|
|
7,170
|
|
|
|
Other non-cash expenses or losses
|
|
3,420
|
|
|
|
Non-recurring expenses or costs
(2)
|
|
1,830
|
|
|
|
Extraordinary, non-recurring or unusual gains or losses
|
|
(3,800
|
)
|
|
|
Business and asset dispositions
|
|
380
|
|
|
|
Casualty or business interruption expenses covered and reimbursed by insurance
|
|
460
|
|
|
|
Consolidated Bank EBITDA, as defined
|
|
$
|
171,640
|
|
|
|
|
December 31, 2018
|
|||
|
Total Indebtedness, as defined
(3)
|
|
$
|
217,990
|
|
|
|
Consolidated Bank EBITDA, as defined
|
|
171,640
|
|
|
|
|
Actual total net leverage ratio
|
|
1.27
|
|
x
|
|
|
Covenant requirement
|
|
4.00
|
|
x
|
|
|
|
|
December 31, 2018
|
|||
|
Total senior secured indebtedness
(4)
|
|
$
|
(85,950
|
)
|
|
|
Consolidated Bank EBITDA, as defined
|
|
171,640
|
|
|
|
|
Senior secured net leverage ratio
|
|
n/m
|
|
x
|
|
|
Covenant requirement
|
|
3.50
|
|
x
|
|
|
|
|
December 31, 2018
|
||
|
Interest expense, as defined
|
|
$
|
13,910
|
|
|
Bank stipulated adjustments:
|
|
|
||
|
Interest income
|
|
(210
|
)
|
|
|
Non-cash amounts attributable to amortization of financing costs
|
|
(1,110
|
)
|
|
|
Total Consolidated Cash Interest Expense, as defined
|
|
$
|
12,590
|
|
|
|
|
December 31, 2018
|
|
||
|
Consolidated Bank EBITDA, as defined
|
|
$
|
171,640
|
|
|
|
Total Consolidated Cash Interest Expense, as defined
|
|
12,590
|
|
|
|
|
Actual interest expense coverage ratio
|
|
13.63
|
|
x
|
|
|
Covenant requirement
|
|
3.00
|
|
x
|
|
|
(1)
|
Non-cash compensation expenses resulting from the grant of equity awards.
|
|
(2)
|
Non-recurring costs and expenses relating to severance, relocation, restructuring and curtailment expenses.
|
|
(3)
|
Includes approximately $4.0 million of acquisition related deferred purchase price as of
December 31, 2018
.
|
|
(4)
|
Senior secured indebtedness is negative at
December 31, 2018
due to the deduction of certain unrestricted cash and unrestricted permitted investments as allowed under the Credit Agreement.
|
|
|
|
Payments Due by Periods
|
||||||||||||||||||
|
|
|
Total
|
|
Less than
One Year
|
|
1 - 3 Years
|
|
3 - 5 Years
|
|
More than
5 Years
|
||||||||||
|
Contractual cash obligations:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Long-term debt
|
|
$
|
300,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
300,000
|
|
|
Operating lease obligations
|
|
65,950
|
|
|
12,730
|
|
|
23,610
|
|
|
13,780
|
|
|
15,830
|
|
|||||
|
Benefit obligations
|
|
13,150
|
|
|
1,030
|
|
|
2,260
|
|
|
2,520
|
|
|
7,340
|
|
|||||
|
Interest obligations
(a)
|
|
102,380
|
|
|
14,630
|
|
|
29,250
|
|
|
29,250
|
|
|
29,250
|
|
|||||
|
Other
|
|
3,950
|
|
|
3,950
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total contractual obligations
|
|
$
|
485,430
|
|
|
$
|
32,340
|
|
|
$
|
55,120
|
|
|
$
|
45,550
|
|
|
$
|
352,420
|
|
|
(a)
|
Our Senior Notes bear interest at 4.875%. Interest on our senior secured revolving credit facility is based on LIBOR plus 150.0 basis points at
December 31, 2018
. These rates were used to estimate our future interest obligations with respect to the long-term debt. These rates exclude the impact of our cross-currency swap agreements. See Note
11
, "
Derivative Instruments
," included in Item 8, "
Financial Statements and Supplementary Data
," within this Form 10-K for additional information.
|
|
|
|
December 31,
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Assets
|
|
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
108,150
|
|
|
$
|
27,580
|
|
|
Receivables, net
|
|
123,110
|
|
|
112,220
|
|
||
|
Inventories
|
|
173,120
|
|
|
155,350
|
|
||
|
Prepaid expenses and other current assets
|
|
7,430
|
|
|
16,120
|
|
||
|
Total current assets
|
|
411,810
|
|
|
311,270
|
|
||
|
Property and equipment, net
|
|
187,800
|
|
|
190,250
|
|
||
|
Goodwill
|
|
316,650
|
|
|
319,390
|
|
||
|
Other intangibles, net
|
|
174,530
|
|
|
194,220
|
|
||
|
Deferred income taxes
|
|
1,080
|
|
|
9,100
|
|
||
|
Other assets
|
|
8,650
|
|
|
8,970
|
|
||
|
Total assets
|
|
$
|
1,100,520
|
|
|
$
|
1,033,200
|
|
|
Liabilities and Shareholders' Equity
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
93,430
|
|
|
$
|
72,410
|
|
|
Accrued liabilities
|
|
48,300
|
|
|
49,470
|
|
||
|
Total current liabilities
|
|
141,730
|
|
|
121,880
|
|
||
|
Long-term debt, net
|
|
293,560
|
|
|
303,080
|
|
||
|
Deferred income taxes
|
|
5,560
|
|
|
5,650
|
|
||
|
Other long-term liabilities
|
|
39,220
|
|
|
58,570
|
|
||
|
Total liabilities
|
|
480,070
|
|
|
489,180
|
|
||
|
Preferred stock $0.01 par: Authorized 100,000,000 shares;
Issued and outstanding: None |
|
—
|
|
|
—
|
|
||
|
Common stock, $0.01 par: Authorized 400,000,000 shares;
Issued and outstanding: 45,527,993 shares at December 31, 2018 and 45,724,453 shares at December 31, 2017 |
|
460
|
|
|
460
|
|
||
|
Paid-in capital
|
|
816,500
|
|
|
823,850
|
|
||
|
Accumulated deficit
|
|
(179,660
|
)
|
|
(262,960
|
)
|
||
|
Accumulated other comprehensive loss
|
|
(16,850
|
)
|
|
(17,330
|
)
|
||
|
Total shareholders' equity
|
|
620,450
|
|
|
544,020
|
|
||
|
Total liabilities and shareholders' equity
|
|
$
|
1,100,520
|
|
|
$
|
1,033,200
|
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net sales
|
|
$
|
877,140
|
|
|
$
|
817,740
|
|
|
$
|
794,020
|
|
|
Cost of sales
|
|
(633,020
|
)
|
|
(598,350
|
)
|
|
(583,220
|
)
|
|||
|
Gross profit
|
|
244,120
|
|
|
219,390
|
|
|
210,800
|
|
|||
|
Selling, general and administrative expenses
|
|
(121,800
|
)
|
|
(129,140
|
)
|
|
(151,960
|
)
|
|||
|
Net loss on dispositions of assets
|
|
(250
|
)
|
|
(1,080
|
)
|
|
(1,870
|
)
|
|||
|
Impairment of goodwill and indefinite-lived intangible assets
|
|
—
|
|
|
—
|
|
|
(98,900
|
)
|
|||
|
Operating profit (loss)
|
|
122,070
|
|
|
89,170
|
|
|
(41,930
|
)
|
|||
|
Other expense, net:
|
|
|
|
|
|
|
||||||
|
Interest expense
|
|
(13,910
|
)
|
|
(14,400
|
)
|
|
(13,720
|
)
|
|||
|
Debt financing and related expenses
|
|
—
|
|
|
(6,640
|
)
|
|
—
|
|
|||
|
Other expense, net
|
|
(2,180
|
)
|
|
(1,920
|
)
|
|
(2,580
|
)
|
|||
|
Other expense, net
|
|
(16,090
|
)
|
|
(22,960
|
)
|
|
(16,300
|
)
|
|||
|
Income (loss) before income taxes
|
|
105,980
|
|
|
66,210
|
|
|
(58,230
|
)
|
|||
|
Income tax benefit (expense)
|
|
(22,680
|
)
|
|
(35,250
|
)
|
|
18,430
|
|
|||
|
Net income (loss)
|
|
83,300
|
|
|
30,960
|
|
|
(39,800
|
)
|
|||
|
Basic earnings (loss) per share:
|
|
|
|
|
|
|
||||||
|
Net income (loss) per share
|
|
$
|
1.82
|
|
|
$
|
0.68
|
|
|
$
|
(0.88
|
)
|
|
Weighted average common shares - basic
|
|
45,824,555
|
|
|
45,682,627
|
|
|
45,407,316
|
|
|||
|
Diluted earnings (loss) per share:
|
|
|
|
|
|
|
||||||
|
Net income (loss) per share
|
|
$
|
1.80
|
|
|
$
|
0.67
|
|
|
$
|
(0.88
|
)
|
|
Weighted average common shares - diluted
|
|
46,170,464
|
|
|
45,990,252
|
|
|
45,407,316
|
|
|||
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net income (loss)
|
|
$
|
83,300
|
|
|
$
|
30,960
|
|
|
$
|
(39,800
|
)
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
||||||
|
Defined benefit plans (Note 14)
|
|
3,250
|
|
|
1,670
|
|
|
250
|
|
|||
|
Foreign currency translation
|
|
(6,880
|
)
|
|
6,050
|
|
|
(12,620
|
)
|
|||
|
Derivative instruments (Note 11)
|
|
4,110
|
|
|
(650
|
)
|
|
(730
|
)
|
|||
|
Total other comprehensive income (loss)
|
|
480
|
|
|
7,070
|
|
|
(13,100
|
)
|
|||
|
Total comprehensive income (loss)
|
|
$
|
83,780
|
|
|
$
|
38,030
|
|
|
$
|
(52,900
|
)
|
|
|
Year ended December 31,
|
||||||||||
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Cash Flows from Operating Activities:
|
|
|
|
|
|
||||||
|
Net income (loss)
|
$
|
83,300
|
|
|
$
|
30,960
|
|
|
$
|
(39,800
|
)
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|
|
|
|
|
||||||
|
Impairment of goodwill and indefinite-lived intangible assets
|
—
|
|
|
—
|
|
|
98,900
|
|
|||
|
Loss on dispositions of assets
|
250
|
|
|
1,080
|
|
|
1,870
|
|
|||
|
Depreciation
|
24,580
|
|
|
26,950
|
|
|
24,390
|
|
|||
|
Amortization of intangible assets
|
19,440
|
|
|
19,920
|
|
|
20,470
|
|
|||
|
Amortization of debt issue costs
|
1,290
|
|
|
1,320
|
|
|
1,370
|
|
|||
|
Deferred income taxes
|
7,200
|
|
|
15,260
|
|
|
(32,160
|
)
|
|||
|
Non-cash compensation expense
|
7,170
|
|
|
6,780
|
|
|
6,940
|
|
|||
|
Debt financing and related expenses
|
—
|
|
|
6,640
|
|
|
—
|
|
|||
|
(Increase) decrease in receivables
|
(11,420
|
)
|
|
1,220
|
|
|
7,990
|
|
|||
|
(Increase) decrease in inventories
|
(18,690
|
)
|
|
4,350
|
|
|
5,180
|
|
|||
|
(Increase) decrease in prepaid expenses and other assets
|
9,060
|
|
|
(310
|
)
|
|
2,550
|
|
|||
|
Increase (decrease) in accounts payable and accrued liabilities
|
4,340
|
|
|
3,640
|
|
|
(18,120
|
)
|
|||
|
Other operating activities
|
2,800
|
|
|
2,250
|
|
|
890
|
|
|||
|
Net cash provided by operating activities
|
129,320
|
|
|
120,060
|
|
|
80,470
|
|
|||
|
Cash Flows from Investing Activities:
|
|
|
|
|
|
||||||
|
Capital expenditures
|
(25,050
|
)
|
|
(36,800
|
)
|
|
(31,330
|
)
|
|||
|
Net proceeds from dispositions of property and equipment
|
250
|
|
|
4,450
|
|
|
220
|
|
|||
|
Net cash used for investing activities
|
(24,800
|
)
|
|
(32,350
|
)
|
|
(31,110
|
)
|
|||
|
Cash Flows from Financing Activities:
|
|
|
|
|
|
||||||
|
Proceeds from borrowings on revolving credit and accounts receivable facilities
|
59,060
|
|
|
401,300
|
|
|
402,420
|
|
|||
|
Repayments of borrowings on revolving credit and accounts receivable facilities
|
(68,490
|
)
|
|
(517,310
|
)
|
|
(433,350
|
)
|
|||
|
Payments to purchase common stock
|
(12,140
|
)
|
|
—
|
|
|
—
|
|
|||
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes
|
(2,380
|
)
|
|
(510
|
)
|
|
(1,590
|
)
|
|||
|
Proceeds from issuance of senior notes
|
—
|
|
|
300,000
|
|
|
—
|
|
|||
|
Repayments of borrowings on term loan facilities
|
—
|
|
|
(257,940
|
)
|
|
(13,850
|
)
|
|||
|
Debt financing fees
|
—
|
|
|
(6,070
|
)
|
|
—
|
|
|||
|
Payments for deferred purchase price
|
—
|
|
|
—
|
|
|
(2,530
|
)
|
|||
|
Other financing activities
|
—
|
|
|
(310
|
)
|
|
800
|
|
|||
|
Net cash used for financing activities
|
(23,950
|
)
|
|
(80,840
|
)
|
|
(48,100
|
)
|
|||
|
Cash and Cash Equivalents:
|
|
|
|
|
|
||||||
|
Increase for the year
|
80,570
|
|
|
6,870
|
|
|
1,260
|
|
|||
|
At beginning of year
|
27,580
|
|
|
20,710
|
|
|
19,450
|
|
|||
|
At end of year
|
$
|
108,150
|
|
|
$
|
27,580
|
|
|
$
|
20,710
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
||||||
|
Cash paid for interest
|
$
|
13,800
|
|
|
$
|
9,430
|
|
|
$
|
11,800
|
|
|
Cash paid for income taxes
|
$
|
7,380
|
|
|
$
|
16,230
|
|
|
$
|
17,210
|
|
|
|
|
Common
Stock
|
|
Paid-In
Capital
|
|
Accumulated
Deficit
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Total
|
||||||||||
|
Balances at December 31, 2015
|
|
$
|
450
|
|
|
$
|
812,160
|
|
|
$
|
(254,120
|
)
|
|
$
|
(11,300
|
)
|
|
$
|
547,190
|
|
|
Net loss
|
|
—
|
|
|
—
|
|
|
(39,800
|
)
|
|
—
|
|
|
(39,800
|
)
|
|||||
|
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(13,100
|
)
|
|
(13,100
|
)
|
|||||
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes
|
|
—
|
|
|
(1,590
|
)
|
|
—
|
|
|
—
|
|
|
(1,590
|
)
|
|||||
|
Stock option exercises and restricted stock vestings
|
|
10
|
|
|
150
|
|
|
—
|
|
|
—
|
|
|
160
|
|
|||||
|
Tax effect from stock based compensation
|
|
—
|
|
|
(80
|
)
|
|
—
|
|
|
—
|
|
|
(80
|
)
|
|||||
|
Non-cash compensation expense
|
|
—
|
|
|
6,940
|
|
|
—
|
|
|
—
|
|
|
6,940
|
|
|||||
|
Balances at December 31, 2016
|
|
$
|
460
|
|
|
$
|
817,580
|
|
|
$
|
(293,920
|
)
|
|
$
|
(24,400
|
)
|
|
$
|
499,720
|
|
|
Net income
|
|
—
|
|
|
—
|
|
|
30,960
|
|
|
—
|
|
|
30,960
|
|
|||||
|
Other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7,070
|
|
|
7,070
|
|
|||||
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes
|
|
—
|
|
|
(510
|
)
|
|
—
|
|
|
—
|
|
|
(510
|
)
|
|||||
|
Non-cash compensation expense
|
|
—
|
|
|
6,780
|
|
|
—
|
|
|
—
|
|
|
6,780
|
|
|||||
|
Balances at December 31, 2017
|
|
$
|
460
|
|
|
$
|
823,850
|
|
|
$
|
(262,960
|
)
|
|
$
|
(17,330
|
)
|
|
$
|
544,020
|
|
|
Net income
|
|
—
|
|
|
—
|
|
|
83,300
|
|
|
—
|
|
|
83,300
|
|
|||||
|
Other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
480
|
|
|
480
|
|
|||||
|
Purchase of common stock
|
|
—
|
|
|
(12,140
|
)
|
|
—
|
|
|
—
|
|
|
(12,140
|
)
|
|||||
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes
|
|
—
|
|
|
(2,380
|
)
|
|
—
|
|
|
—
|
|
|
(2,380
|
)
|
|||||
|
Non-cash compensation expense
|
|
—
|
|
|
7,170
|
|
|
—
|
|
|
—
|
|
|
7,170
|
|
|||||
|
Balances at December 31, 2018
|
|
$
|
460
|
|
|
$
|
816,500
|
|
|
$
|
(179,660
|
)
|
|
$
|
(16,850
|
)
|
|
$
|
620,450
|
|
|
•
|
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
|
|
•
|
Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and
|
|
•
|
Level 3 inputs are unobservable inputs for the asset or liability.
|
|
|
|
Year ended December 31,
|
||||||||||
|
Customer End Markets
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Consumer
|
|
$
|
276,740
|
|
|
$
|
259,470
|
|
|
$
|
259,390
|
|
|
Aerospace
|
|
185,920
|
|
|
184,310
|
|
|
174,920
|
|
|||
|
Industrial
|
|
212,160
|
|
|
189,550
|
|
|
182,280
|
|
|||
|
Oil and gas
|
|
202,320
|
|
|
184,410
|
|
|
177,430
|
|
|||
|
Total net sales
|
|
$
|
877,140
|
|
|
$
|
817,740
|
|
|
$
|
794,020
|
|
|
|
|
|
|
|
Specialty
|
|
|
||||||||
|
|
Packaging
|
|
Aerospace
|
|
Products
|
|
Total
|
||||||||
|
Balance, December 31, 2016
|
$
|
162,090
|
|
|
$
|
146,430
|
|
|
$
|
6,560
|
|
|
$
|
315,080
|
|
|
Foreign currency translation and other
|
4,310
|
|
|
—
|
|
|
—
|
|
|
4,310
|
|
||||
|
Balance, December 31, 2017
|
$
|
166,400
|
|
|
$
|
146,430
|
|
|
$
|
6,560
|
|
|
$
|
319,390
|
|
|
Foreign currency translation and other
|
(2,740
|
)
|
|
—
|
|
|
—
|
|
|
(2,740
|
)
|
||||
|
Balance, December 31, 2018
|
$
|
163,660
|
|
|
$
|
146,430
|
|
|
$
|
6,560
|
|
|
$
|
316,650
|
|
|
|
|
As of December 31, 2018
|
|
As of December 31, 2017
|
||||||||||||
|
Intangible Category by Useful Life
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
||||||||
|
Finite-lived intangible assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Customer relationships, 5 - 12 years
|
|
$
|
73,450
|
|
|
$
|
(48,410
|
)
|
|
$
|
73,910
|
|
|
$
|
(41,000
|
)
|
|
Customer relationships, 15 - 25 years
|
|
132,230
|
|
|
(58,790
|
)
|
|
132,230
|
|
|
(51,880
|
)
|
||||
|
Total customer relationships
|
|
205,680
|
|
|
(107,200
|
)
|
|
206,140
|
|
|
(92,880
|
)
|
||||
|
Technology and other, 1 - 15 years
|
|
57,020
|
|
|
(31,600
|
)
|
|
57,340
|
|
|
(29,120
|
)
|
||||
|
Technology and other, 17 - 30 years
|
|
43,300
|
|
|
(35,600
|
)
|
|
43,300
|
|
|
(33,490
|
)
|
||||
|
Total technology and other
|
|
100,320
|
|
|
(67,200
|
)
|
|
100,640
|
|
|
(62,610
|
)
|
||||
|
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Trademark/Trade names
|
|
42,930
|
|
|
—
|
|
|
42,930
|
|
|
—
|
|
||||
|
Total other intangible assets
|
|
$
|
348,930
|
|
|
$
|
(174,400
|
)
|
|
$
|
349,710
|
|
|
$
|
(155,490
|
)
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Technology and other, included in cost of sales
|
|
$
|
4,900
|
|
|
$
|
5,340
|
|
|
$
|
5,680
|
|
|
Customer relationships, included in selling, general and administrative expenses
|
|
14,540
|
|
|
14,580
|
|
|
14,790
|
|
|||
|
Total amortization expense
|
|
$
|
19,440
|
|
|
$
|
19,920
|
|
|
$
|
20,470
|
|
|
Year ended December 31,
|
Estimated Amortization Expense
|
|||
|
2019
|
|
$
|
19,080
|
|
|
2020
|
|
$
|
18,140
|
|
|
2021
|
|
$
|
15,360
|
|
|
2022
|
|
$
|
11,810
|
|
|
2023
|
|
$
|
9,910
|
|
|
|
|
December 31,
2018 |
|
December 31,
2017 |
||||
|
Finished goods
|
|
$
|
91,780
|
|
|
$
|
86,310
|
|
|
Work in process
|
|
29,080
|
|
|
24,580
|
|
||
|
Raw materials
|
|
52,260
|
|
|
44,460
|
|
||
|
Total inventories
|
|
$
|
173,120
|
|
|
$
|
155,350
|
|
|
|
|
December 31,
2018 |
|
December 31,
2017 |
||||
|
Land and land improvements
|
|
$
|
15,580
|
|
|
$
|
15,500
|
|
|
Building and building improvements
|
|
74,110
|
|
|
73,550
|
|
||
|
Machinery and equipment
|
|
318,860
|
|
|
303,880
|
|
||
|
|
|
408,550
|
|
|
392,930
|
|
||
|
Less: Accumulated depreciation
|
|
220,750
|
|
|
202,680
|
|
||
|
Property and equipment, net
|
|
$
|
187,800
|
|
|
$
|
190,250
|
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Depreciation expense, included in cost of sales
|
|
$
|
22,940
|
|
|
$
|
24,950
|
|
|
$
|
21,620
|
|
|
Depreciation expense, included in selling, general and administrative expense
|
|
1,640
|
|
|
2,000
|
|
|
2,770
|
|
|||
|
Total depreciation expense
|
|
$
|
24,580
|
|
|
$
|
26,950
|
|
|
$
|
24,390
|
|
|
|
|
December 31,
2018 |
|
December 31,
2017 |
||||
|
High deductible insurance
|
|
$
|
6,090
|
|
|
$
|
6,250
|
|
|
Accrued payroll
|
|
20,830
|
|
|
19,060
|
|
||
|
Other
|
|
21,380
|
|
|
24,160
|
|
||
|
Total accrued liabilities
|
|
$
|
48,300
|
|
|
$
|
49,470
|
|
|
|
|
December 31,
2018 |
|
December 31,
2017 |
||||
|
4.875% Senior Notes due October 2025
|
|
$
|
300,000
|
|
|
$
|
300,000
|
|
|
Credit Agreement
|
|
—
|
|
|
10,810
|
|
||
|
Debt issuance costs
|
|
(6,440
|
)
|
|
(7,730
|
)
|
||
|
Long-term debt, net
|
|
$
|
293,560
|
|
|
$
|
303,080
|
|
|
Year
|
|
Percentage
|
|
|
2020
|
|
102.438
|
%
|
|
2021
|
|
101.219
|
%
|
|
2022 and thereafter
|
|
100.000
|
%
|
|
Year Ending December 31:
|
|
Future Maturities
|
||
|
2019
|
|
$
|
—
|
|
|
2020
|
|
—
|
|
|
|
2021
|
|
—
|
|
|
|
2022
|
|
—
|
|
|
|
2023
|
|
—
|
|
|
|
Thereafter
|
|
300,000
|
|
|
|
Total
|
|
$
|
300,000
|
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||||||||||
|
|
|
Carrying Amount
|
|
Fair Value
|
|
Carrying Amount
|
|
Fair Value
|
||||||||
|
Senior Notes
|
|
$
|
300,000
|
|
|
$
|
282,750
|
|
|
$
|
300,000
|
|
|
$
|
300,750
|
|
|
Revolving credit facility
|
|
—
|
|
|
—
|
|
|
10,810
|
|
|
10,490
|
|
||||
|
|
|
|
|
Asset / (Liability) Derivatives
|
||||||
|
Derivatives designated as hedging instruments
|
|
Balance Sheet Caption
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Net Investment Hedges
|
|
|
|
|
|
|
||||
|
Cross-currency swaps
|
|
Other assets
|
|
$
|
130
|
|
|
$
|
—
|
|
|
Cross-currency swaps
|
|
Other long-term liabilities
|
|
—
|
|
|
(4,110
|
)
|
||
|
|
|
Amount of Income (Loss) Recognized
in AOCI on Derivative (Effective Portion, net of tax) |
|
Location of Loss Reclassified from AOCI into Earnings
(Effective Portion) |
|
Amount of Loss Reclassified from
AOCI into Earnings |
||||||||||||||||
|
|
|
As of December 31,
|
|
|
Year ended December 31,
|
|||||||||||||||||
|
|
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||||||
|
Net Investment Hedges
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cross-currency swaps
|
|
$
|
940
|
|
|
$
|
(3,170
|
)
|
|
Other expense, net
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Cash Flow Hedges
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Interest rate swaps
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Interest expense
|
|
$
|
—
|
|
|
$
|
(320
|
)
|
|
$
|
(670
|
)
|
|
|
|
|
|
|
|
Debt financing and related expenses
|
|
$
|
—
|
|
|
$
|
(4,680
|
)
|
|
$
|
—
|
|
||||
|
|
Description
|
|
Frequency
|
|
Asset / (Liability)
|
|
Quoted Prices in Active Markets for Identical Assets
(Level 1) |
|
Significant Other Observable Inputs
(Level 2) |
|
Significant Unobservable Inputs
(Level 3) |
||||||||
|
December 31, 2018
|
Cross-currency swaps
|
|
Recurring
|
|
$
|
130
|
|
|
$
|
—
|
|
|
$
|
130
|
|
|
$
|
—
|
|
|
December 31, 2017
|
Cross-currency swaps
|
|
Recurring
|
|
$
|
(4,110
|
)
|
|
$
|
—
|
|
|
$
|
(4,110
|
)
|
|
$
|
—
|
|
|
Year ended December 31,
|
|
Minimum Payments
|
||
|
2019
|
|
$
|
12,730
|
|
|
2020
|
|
12,530
|
|
|
|
2021
|
|
11,080
|
|
|
|
2022
|
|
7,510
|
|
|
|
2023
|
|
6,270
|
|
|
|
Thereafter
|
|
15,830
|
|
|
|
Total
|
|
$
|
65,950
|
|
|
|
|
Claims
pending at
beginning of
period
|
|
Claims filed
during
period
|
|
Claims
dismissed
during
period
|
|
Claims
settled
during
period
|
|
Claims
pending at end of period |
|
Average
settlement
amount per
claim during
period
|
|
Total defense
costs during
period
|
|||||||||
|
Fiscal year ended December 31, 2018
|
|
5,256
|
|
|
171
|
|
|
564
|
|
|
43
|
|
|
4,820
|
|
|
$
|
7,191
|
|
|
$
|
2,260,000
|
|
|
Fiscal year ended December 31, 2017
|
|
5,339
|
|
|
173
|
|
|
231
|
|
|
25
|
|
|
5,256
|
|
|
$
|
8,930
|
|
|
$
|
2,280,000
|
|
|
Fiscal year ended December 31, 2016
|
|
6,242
|
|
|
140
|
|
|
1,009
|
|
|
34
|
|
|
5,339
|
|
|
$
|
15,624
|
|
|
$
|
2,920,000
|
|
|
|
Compensatory
|
||||
|
Range of damages sought (in millions)
|
$0.0 to $0.6
|
|
$0.6 to $5.0
|
|
$5.0+
|
|
Number of claims
|
—
|
|
12
|
|
37
|
|
|
|
Pension Benefit
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Service cost
|
|
$
|
1,120
|
|
|
$
|
1,150
|
|
|
$
|
950
|
|
|
Interest cost
|
|
1,100
|
|
|
1,290
|
|
|
1,510
|
|
|||
|
Expected return on plan assets
|
|
(1,520
|
)
|
|
(1,480
|
)
|
|
(1,610
|
)
|
|||
|
Settlements and curtailments
|
|
2,620
|
|
|
—
|
|
|
1,330
|
|
|||
|
Amortization of net loss
|
|
860
|
|
|
1,010
|
|
|
930
|
|
|||
|
Net periodic benefit expense
|
|
$
|
4,180
|
|
|
$
|
1,970
|
|
|
$
|
3,110
|
|
|
|
|
Pension Benefit
|
|||||||
|
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Discount rate for obligations
|
|
4.50
|
%
|
|
3.76
|
%
|
|
4.35
|
%
|
|
Discount rate for benefit costs
|
|
4.37
|
%
|
|
4.35
|
%
|
|
4.62
|
%
|
|
Rate of increase in compensation levels
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
Expected long-term rate of return on plan assets
|
|
7.13
|
%
|
|
7.13
|
%
|
|
7.13
|
%
|
|
|
|
Pension Benefit
|
|||||||
|
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Discount rate for obligations
|
|
3.00
|
%
|
|
2.60
|
%
|
|
2.80
|
%
|
|
Discount rate for benefit costs
|
|
2.60
|
%
|
|
2.80
|
%
|
|
3.80
|
%
|
|
Rate of increase in compensation levels
|
|
3.30
|
%
|
|
3.30
|
%
|
|
3.90
|
%
|
|
Expected long-term rate of return on plan assets
|
|
4.60
|
%
|
|
4.60
|
%
|
|
4.90
|
%
|
|
|
|
Pension Benefit
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Changes in Projected Benefit Obligations
|
|
|
|
|
||||
|
Benefit obligations at January 1
|
|
$
|
(39,030
|
)
|
|
$
|
(37,640
|
)
|
|
Service cost
|
|
(1,120
|
)
|
|
(1,150
|
)
|
||
|
Interest cost
|
|
(1,100
|
)
|
|
(1,290
|
)
|
||
|
Participant contributions
|
|
(60
|
)
|
|
(60
|
)
|
||
|
Actuarial gain
|
|
3,020
|
|
|
990
|
|
||
|
Benefit payments
|
|
1,200
|
|
|
1,320
|
|
||
|
Annuity purchase
|
|
5,480
|
|
|
—
|
|
||
|
Settlements and curtailments
|
|
210
|
|
|
710
|
|
||
|
Change in foreign currency
|
|
1,100
|
|
|
(1,910
|
)
|
||
|
Projected benefit obligations at December 31
|
|
$
|
(30,300
|
)
|
|
$
|
(39,030
|
)
|
|
Changes in Plan Assets
|
|
|
|
|
||||
|
Fair value of plan assets at January 1
|
|
$
|
31,760
|
|
|
$
|
26,260
|
|
|
Actual return on plan assets
|
|
(1,520
|
)
|
|
2,510
|
|
||
|
Employer contributions
|
|
2,440
|
|
|
3,170
|
|
||
|
Participant contributions
|
|
60
|
|
|
60
|
|
||
|
Benefit payments
|
|
(1,200
|
)
|
|
(1,320
|
)
|
||
|
Annuity purchase
|
|
(5,480
|
)
|
|
—
|
|
||
|
Settlements
|
|
(210
|
)
|
|
(710
|
)
|
||
|
Change in foreign currency
|
|
(1,200
|
)
|
|
1,790
|
|
||
|
Fair value of plan assets at December 31
|
|
$
|
24,650
|
|
|
$
|
31,760
|
|
|
Funded status at December 31
|
|
$
|
(5,650
|
)
|
|
$
|
(7,270
|
)
|
|
|
|
Pension Benefit
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Amounts Recognized in Balance Sheet
|
|
|
|
|
||||
|
Prepaid benefit cost
|
|
$
|
1,350
|
|
|
$
|
1,190
|
|
|
Current liabilities
|
|
(340
|
)
|
|
(340
|
)
|
||
|
Noncurrent liabilities
|
|
(6,660
|
)
|
|
(8,120
|
)
|
||
|
Net liability recognized at December 31
|
|
$
|
(5,650
|
)
|
|
$
|
(7,270
|
)
|
|
|
|
Pension Benefit
|
||||||
|
|
|
2018
|
|
2017
|
||||
|
Amounts Recognized in Accumulated Other Comprehensive Loss
|
|
|
|
|
||||
|
Unrecognized prior service cost
|
|
$
|
190
|
|
|
$
|
50
|
|
|
Unrecognized net loss
|
|
11,610
|
|
|
15,600
|
|
||
|
Total accumulated other comprehensive loss recognized at December 31
|
|
$
|
11,800
|
|
|
$
|
15,650
|
|
|
|
|
Accumulated Benefit Obligations
|
|
Projected Benefit Obligations
|
||||||||||||
|
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
||||||||
|
Benefit Obligations at December 31,
|
|
|
|
|
|
|
|
|
||||||||
|
Total benefit obligations
|
|
$
|
(28,410
|
)
|
|
$
|
(36,720
|
)
|
|
$
|
(30,300
|
)
|
|
$
|
(39,030
|
)
|
|
Plans with benefit obligations exceeding plan assets
|
|
|
|
|
|
|
|
|
||||||||
|
Benefit obligations
|
|
$
|
(12,050
|
)
|
|
$
|
(18,420
|
)
|
|
$
|
(12,080
|
)
|
|
$
|
(18,440
|
)
|
|
Plan assets
|
|
5,090
|
|
|
9,980
|
|
|
5,090
|
|
|
9,980
|
|
||||
|
|
|
Pension Benefit
|
||||||
|
|
|
December 31, 2018
Benefit Obligation |
|
2018 Expense
|
||||
|
Discount rate
|
|
|
|
|
||||
|
25 basis point increase
|
|
$
|
(1,120
|
)
|
|
$
|
(90
|
)
|
|
25 basis point decrease
|
|
$
|
1,210
|
|
|
$
|
100
|
|
|
Expected return on assets
|
|
|
|
|
||||
|
50 basis point increase
|
|
N/A
|
|
|
$
|
(130
|
)
|
|
|
50 basis point decrease
|
|
N/A
|
|
|
$
|
130
|
|
|
|
|
|
Domestic Pension
|
|
Foreign Pension
|
||||||||||||||
|
|
|
|
|
Actual
|
|
|
|
Actual
|
||||||||||
|
|
|
Target
|
|
2018
|
|
2017
|
|
Target
|
|
2018
|
|
2017
|
||||||
|
Equity securities
|
|
60
|
%
|
|
58
|
%
|
|
63
|
%
|
|
33
|
%
|
|
29
|
%
|
|
30
|
%
|
|
Fixed income
|
|
36
|
%
|
|
39
|
%
|
|
36
|
%
|
|
45
|
%
|
|
47
|
%
|
|
46
|
%
|
|
Diversified growth
(a)
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
22
|
%
|
|
24
|
%
|
|
24
|
%
|
|
Cash and other
|
|
4
|
%
|
|
3
|
%
|
|
1
|
%
|
|
—
|
|
|
—
|
%
|
|
—
|
%
|
|
Total
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Plan assets subject to leveling
|
|
|
|
|
|
|
|
|
||||||||
|
Investment funds
|
|
|
|
|
|
|
|
|
||||||||
|
Equity securities
|
|
$
|
2,960
|
|
|
$
|
2,960
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Fixed income
|
|
1,970
|
|
|
1,970
|
|
|
—
|
|
|
—
|
|
||||
|
Cash and cash equivalents
|
|
90
|
|
|
90
|
|
|
—
|
|
|
—
|
|
||||
|
Plan assets measured at net asset value
(a)
|
|
|
|
|
|
|
|
|
||||||||
|
Investment funds
|
|
|
|
|
|
|
|
|
||||||||
|
Equity securities
|
|
5,590
|
|
|
|
|
|
|
|
|||||||
|
Fixed income
|
|
9,400
|
|
|
|
|
|
|
|
|||||||
|
Diversified growth
|
|
4,390
|
|
|
|
|
|
|
|
|||||||
|
Cash and cash equivalents
|
|
250
|
|
|
|
|
|
|
|
|||||||
|
Total
|
|
$
|
24,650
|
|
|
$
|
5,020
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
Pension
Benefit
|
||
|
December 31, 2019
|
|
$
|
990
|
|
|
December 31, 2020
|
|
1,110
|
|
|
|
December 31, 2021
|
|
1,090
|
|
|
|
December 31, 2022
|
|
1,190
|
|
|
|
December 31, 2023
|
|
1,290
|
|
|
|
Years 2024-2028
|
|
7,260
|
|
|
|
Plan Names
|
|
Shares Approved for Issuance
|
|
|
TriMas Corporation 2017 Equity and Incentive Compensation Plan
|
|
2,000,000
|
|
|
TriMas Corporation Director Retainer Share Election Program
|
|
100,000
|
|
|
|
|
Number of
Stock Options
|
|
Weighted Average
Option Price
|
|
Average
Remaining
Contractual Life (Years)
|
|
Aggregate
Intrinsic Value
|
|||||
|
Outstanding at January 1, 2018
|
|
206,854
|
|
|
$
|
13.19
|
|
|
|
|
|
||
|
Granted
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Exercised
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Cancelled
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Expired
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Outstanding at December 31, 2018
|
|
206,854
|
|
|
$
|
13.19
|
|
|
5.5
|
|
$
|
2,915,651
|
|
|
|
|
Number of
Unvested
Restricted
Shares
|
|
Weighted
Average
Grant Date
Fair Value
|
|
Average
Remaining
Contractual
Life (Years)
|
|
Aggregate
Intrinsic Value
|
|||||
|
Outstanding at January 1, 2018
|
|
726,936
|
|
|
$
|
22.60
|
|
|
|
|
|
||
|
Granted
|
|
309,849
|
|
|
30.29
|
|
|
|
|
|
|||
|
Vested
|
|
(338,141
|
)
|
|
21.60
|
|
|
|
|
|
|||
|
Cancelled
|
|
(35,516
|
)
|
|
23.24
|
|
|
|
|
|
|||
|
Outstanding at December 31, 2018
|
|
663,128
|
|
|
$
|
26.67
|
|
|
1.0
|
|
$
|
18,096,763
|
|
|
|
|
Year ended December 31,
|
|||||||
|
|
|
2018
|
|
2017
|
|
2016
|
|||
|
Weighted average common shares—basic
|
|
45,824,555
|
|
|
45,682,627
|
|
|
45,407,316
|
|
|
Dilutive effect of restricted share awards
|
|
242,204
|
|
|
241,974
|
|
|
—
|
|
|
Dilutive effect of stock options
|
|
103,705
|
|
|
65,651
|
|
|
—
|
|
|
Weighted average common shares—diluted
|
|
46,170,464
|
|
|
45,990,252
|
|
|
45,407,316
|
|
|
|
|
Defined Benefit Plans
|
|
Derivative Instruments
|
|
Foreign Currency Translation
|
|
Total
|
||||||||
|
Balance, December 31, 2017
|
|
$
|
(10,450
|
)
|
|
$
|
(3,170
|
)
|
|
$
|
(3,710
|
)
|
|
$
|
(17,330
|
)
|
|
Net unrealized gains (losses) arising during the period
(a)
|
|
—
|
|
|
4,110
|
|
|
(6,880
|
)
|
|
(2,770
|
)
|
||||
|
Less: Net realized losses reclassified to net income
(b)
|
|
(3,250
|
)
|
|
—
|
|
|
—
|
|
|
(3,250
|
)
|
||||
|
Net current-period other comprehensive income (loss)
|
|
3,250
|
|
|
4,110
|
|
|
(6,880
|
)
|
|
480
|
|
||||
|
Balance, December 31, 2018
|
|
$
|
(7,200
|
)
|
|
$
|
940
|
|
|
$
|
(10,590
|
)
|
|
$
|
(16,850
|
)
|
|
|
|
Defined Benefit Plans
|
|
Derivative Instruments
|
|
Foreign Currency Translation
|
|
Total
|
||||||||
|
Balance, December 31, 2016
|
|
$
|
(12,120
|
)
|
|
$
|
(2,520
|
)
|
|
$
|
(9,760
|
)
|
|
$
|
(24,400
|
)
|
|
Net unrealized gains (losses) arising during the period
(a)
|
|
1,000
|
|
|
(3,750
|
)
|
|
6,050
|
|
|
3,300
|
|
||||
|
Less: Net realized losses reclassified to net income
(b)
|
|
(670
|
)
|
|
(3,100
|
)
|
|
—
|
|
|
(3,770
|
)
|
||||
|
Net current-period other comprehensive income (loss)
|
|
1,670
|
|
|
(650
|
)
|
|
6,050
|
|
|
7,070
|
|
||||
|
Balance, December 31, 2017
|
|
$
|
(10,450
|
)
|
|
$
|
(3,170
|
)
|
|
$
|
(3,710
|
)
|
|
$
|
(17,330
|
)
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Net Sales
|
|
|
|
|
|
|
||||||
|
Packaging
|
|
$
|
368,200
|
|
|
$
|
344,570
|
|
|
$
|
341,340
|
|
|
Aerospace
|
|
185,920
|
|
|
184,310
|
|
|
174,920
|
|
|||
|
Specialty Products
|
|
323,020
|
|
|
288,860
|
|
|
277,760
|
|
|||
|
Total
|
|
$
|
877,140
|
|
|
$
|
817,740
|
|
|
$
|
794,020
|
|
|
Operating Profit (Loss)
|
|
|
|
|
|
|
||||||
|
Packaging
|
|
$
|
84,590
|
|
|
$
|
80,610
|
|
|
$
|
78,630
|
|
|
Aerospace
|
|
27,290
|
|
|
26,410
|
|
|
(90,540
|
)
|
|||
|
Specialty Products
|
|
34,260
|
|
|
12,280
|
|
|
2,900
|
|
|||
|
Corporate
|
|
(24,070
|
)
|
|
(30,130
|
)
|
|
(32,920
|
)
|
|||
|
Total
|
|
$
|
122,070
|
|
|
$
|
89,170
|
|
|
$
|
(41,930
|
)
|
|
Capital Expenditures
|
|
|
|
|
|
|
||||||
|
Packaging
|
|
$
|
13,590
|
|
|
$
|
17,140
|
|
|
$
|
19,880
|
|
|
Aerospace
|
|
1,190
|
|
|
3,370
|
|
|
3,950
|
|
|||
|
Specialty Products
|
|
5,380
|
|
|
6,830
|
|
|
7,470
|
|
|||
|
Corporate
(a)
|
|
4,890
|
|
|
9,460
|
|
|
30
|
|
|||
|
Total
|
|
$
|
25,050
|
|
|
$
|
36,800
|
|
|
$
|
31,330
|
|
|
Depreciation and Amortization
|
|
|
|
|
|
|
||||||
|
Packaging
|
|
$
|
21,620
|
|
|
$
|
21,630
|
|
|
$
|
22,120
|
|
|
Aerospace
|
|
15,190
|
|
|
14,530
|
|
|
14,090
|
|
|||
|
Specialty Products
|
|
6,930
|
|
|
10,530
|
|
|
8,370
|
|
|||
|
Corporate
|
|
280
|
|
|
180
|
|
|
280
|
|
|||
|
Total
|
|
$
|
44,020
|
|
|
$
|
46,870
|
|
|
$
|
44,860
|
|
|
Total Assets
|
|
|
|
|
|
|
||||||
|
Packaging
|
|
$
|
435,140
|
|
|
$
|
431,680
|
|
|
$
|
423,460
|
|
|
Aerospace
|
|
392,140
|
|
|
401,060
|
|
|
409,040
|
|
|||
|
Specialty Products
|
|
181,700
|
|
|
172,840
|
|
|
179,160
|
|
|||
|
Corporate
|
|
91,540
|
|
|
27,620
|
|
|
39,990
|
|
|||
|
Total
|
|
$
|
1,100,520
|
|
|
$
|
1,033,200
|
|
|
$
|
1,051,650
|
|
|
|
|
As of December 31,
|
||||||||||||||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||||||||||||||
|
|
|
Net
Sales
|
|
Long-lived Assets
|
|
Net
Sales
|
|
Long-lived Assets
|
|
Net
Sales
|
|
Long-lived Assets
|
||||||||||||
|
Non-U.S.
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Europe
|
|
$
|
62,420
|
|
|
$
|
54,340
|
|
|
$
|
62,360
|
|
|
$
|
54,790
|
|
|
$
|
65,490
|
|
|
$
|
45,050
|
|
|
Asia Pacific
|
|
45,040
|
|
|
45,160
|
|
|
36,630
|
|
|
51,120
|
|
|
32,230
|
|
|
51,060
|
|
||||||
|
Other Americas
|
|
14,670
|
|
|
7,830
|
|
|
15,260
|
|
|
7,930
|
|
|
13,620
|
|
|
7,800
|
|
||||||
|
Total non-U.S.
|
|
122,130
|
|
|
107,330
|
|
|
114,250
|
|
|
113,840
|
|
|
111,340
|
|
|
103,910
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total U.S.
|
|
755,010
|
|
|
571,650
|
|
|
703,490
|
|
|
590,020
|
|
|
682,680
|
|
|
604,250
|
|
||||||
|
Total
|
|
$
|
877,140
|
|
|
$
|
678,980
|
|
|
$
|
817,740
|
|
|
$
|
703,860
|
|
|
$
|
794,020
|
|
|
$
|
708,160
|
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
Income (loss) before income taxes:
|
|
|
|
|
|
|
||||||
|
Domestic
|
|
$
|
75,830
|
|
|
$
|
50,760
|
|
|
$
|
(69,850
|
)
|
|
Foreign
|
|
30,150
|
|
|
15,450
|
|
|
11,620
|
|
|||
|
Total income (loss) before income taxes
|
|
$
|
105,980
|
|
|
$
|
66,210
|
|
|
$
|
(58,230
|
)
|
|
Current income tax expense:
|
|
|
|
|
|
|
||||||
|
Federal
|
|
$
|
6,770
|
|
|
$
|
12,800
|
|
|
$
|
7,560
|
|
|
State and local
|
|
2,440
|
|
|
1,770
|
|
|
1,920
|
|
|||
|
Foreign
|
|
7,070
|
|
|
5,420
|
|
|
4,250
|
|
|||
|
Total current income tax expense
|
|
16,280
|
|
|
19,990
|
|
|
13,730
|
|
|||
|
Deferred income tax expense (benefit):
|
|
|
|
|
|
|
||||||
|
Federal
|
|
4,540
|
|
|
15,180
|
|
|
(28,180
|
)
|
|||
|
State and local
|
|
1,310
|
|
|
1,280
|
|
|
(2,550
|
)
|
|||
|
Foreign
|
|
550
|
|
|
(1,200
|
)
|
|
(1,430
|
)
|
|||
|
Total deferred income tax expense (benefit)
|
|
6,400
|
|
|
15,260
|
|
|
(32,160
|
)
|
|||
|
Income tax expense (benefit)
|
|
$
|
22,680
|
|
|
$
|
35,250
|
|
|
$
|
(18,430
|
)
|
|
|
|
December 31, 2018
|
|
December 31, 2017
|
||||
|
Deferred tax assets:
|
|
|
|
|
||||
|
Accounts receivable
|
|
$
|
310
|
|
|
$
|
1,000
|
|
|
Inventories
|
|
1,900
|
|
|
5,230
|
|
||
|
Accrued liabilities and other long-term liabilities
|
|
7,220
|
|
|
20,350
|
|
||
|
Tax loss and credit carryforwards
|
|
6,990
|
|
|
7,290
|
|
||
|
Gross deferred tax asset
|
|
16,420
|
|
|
33,870
|
|
||
|
Valuation allowances
|
|
(5,520
|
)
|
|
(6,400
|
)
|
||
|
Net deferred tax asset
|
|
10,900
|
|
|
27,470
|
|
||
|
Deferred tax liabilities:
|
|
|
|
|
||||
|
Property and equipment
|
|
(8,770
|
)
|
|
(16,380
|
)
|
||
|
Goodwill and other intangible assets
|
|
(4,940
|
)
|
|
(5,350
|
)
|
||
|
Investment in foreign affiliates, including withholding tax
|
|
(1,050
|
)
|
|
(740
|
)
|
||
|
Other, principally deferred income
|
|
(620
|
)
|
|
(1,550
|
)
|
||
|
Gross deferred tax liability
|
|
(15,380
|
)
|
|
(24,020
|
)
|
||
|
Net deferred tax asset (liability)
|
|
$
|
(4,480
|
)
|
|
$
|
3,450
|
|
|
|
|
Year ended December 31,
|
||||||||||
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
|
U.S. federal statutory rate
|
|
21
|
%
|
|
35
|
%
|
|
35
|
%
|
|||
|
Tax at U.S. federal statutory rate
|
|
$
|
22,250
|
|
|
$
|
23,170
|
|
|
$
|
(20,380
|
)
|
|
State and local taxes, net of federal tax benefit
|
|
3,030
|
|
|
2,250
|
|
|
(550
|
)
|
|||
|
Differences in statutory foreign tax rates
|
|
380
|
|
|
(2,580
|
)
|
|
(1,930
|
)
|
|||
|
Change in recognized tax benefits
|
|
(270
|
)
|
|
(480
|
)
|
|
(1,410
|
)
|
|||
|
Goodwill and other intangible assets impairment
|
|
—
|
|
|
—
|
|
|
5,050
|
|
|||
|
Nontaxable income
|
|
(940
|
)
|
|
(1,050
|
)
|
|
(310
|
)
|
|||
|
Research and manufacturing incentives
|
|
(1,740
|
)
|
|
(1,510
|
)
|
|
(830
|
)
|
|||
|
Net change in valuation allowance
|
|
650
|
|
|
520
|
|
|
2,140
|
|
|||
|
Tax Reform Act
|
|
(400
|
)
|
|
12,660
|
|
|
—
|
|
|||
|
Other, net
|
|
(280
|
)
|
|
2,270
|
|
|
(210
|
)
|
|||
|
Income tax expense (benefit)
|
|
$
|
22,680
|
|
|
$
|
35,250
|
|
|
$
|
(18,430
|
)
|
|
|
|
Unrecognized
Tax Benefits
|
||
|
Balance at December 31, 2016
|
|
$
|
3,570
|
|
|
Tax positions related to current year:
|
|
|
||
|
Additions
|
|
250
|
|
|
|
Tax positions related to prior years:
|
|
|
||
|
Additions
|
|
860
|
|
|
|
Reductions
|
|
(100
|
)
|
|
|
Settlements
|
|
—
|
|
|
|
Lapses in the statutes of limitations
|
|
(1,210
|
)
|
|
|
Balance at December 31, 2017
|
|
$
|
3,370
|
|
|
Tax positions related to current year:
|
|
|
||
|
Additions
|
|
60
|
|
|
|
Tax positions related to prior years:
|
|
|
|
|
|
Additions
|
|
390
|
|
|
|
Reductions
|
|
—
|
|
|
|
Settlements
|
|
—
|
|
|
|
Lapses in the statutes of limitations
|
|
(800
|
)
|
|
|
Balance at December 31, 2018
|
|
$
|
3,020
|
|
|
|
|
As of December 31, 2018
|
||||||||||||||
|
|
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
||||||||
|
Net sales
|
|
$
|
217,100
|
|
|
$
|
224,910
|
|
|
$
|
223,780
|
|
|
$
|
211,350
|
|
|
Gross profit
|
|
60,380
|
|
|
64,780
|
|
|
61,720
|
|
|
57,240
|
|
||||
|
Net income
|
|
24,320
|
|
|
19,600
|
|
|
22,670
|
|
|
16,710
|
|
||||
|
Earnings per share—basic:
|
|
|
|
|
|
|
|
|
||||||||
|
Net income per share
|
|
$
|
0.53
|
|
|
$
|
0.43
|
|
|
$
|
0.49
|
|
|
$
|
0.37
|
|
|
Weighted average shares—basic
|
|
45,779,966
|
|
|
45,920,307
|
|
|
45,850,288
|
|
|
45,747,659
|
|
||||
|
Earnings per share—diluted:
|
|
|
|
|
|
|
|
|
||||||||
|
Net income per share
|
|
$
|
0.53
|
|
|
$
|
0.42
|
|
|
$
|
0.49
|
|
|
$
|
0.36
|
|
|
Weighted average shares—diluted
|
|
46,229,337
|
|
|
46,200,757
|
|
|
46,166,558
|
|
|
46,085,202
|
|
||||
|
|
|
As of December 31, 2017
|
||||||||||||||
|
|
|
First Quarter
|
|
Second Quarter
|
|
Third Quarter
|
|
Fourth Quarter
|
||||||||
|
Net sales
|
|
$
|
199,830
|
|
|
$
|
213,370
|
|
|
$
|
209,330
|
|
|
$
|
195,210
|
|
|
Gross profit
|
|
51,820
|
|
|
59,470
|
|
|
58,890
|
|
|
49,210
|
|
||||
|
Net income (loss)
|
|
6,990
|
|
|
14,850
|
|
|
13,130
|
|
|
(4,010
|
)
|
||||
|
Earnings (loss) per share—basic:
|
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss) per share
|
|
$
|
0.15
|
|
|
$
|
0.32
|
|
|
$
|
0.29
|
|
|
$
|
(0.09
|
)
|
|
Weighted average shares—basic
|
|
45,570,495
|
|
|
45,717,697
|
|
|
45,721,155
|
|
|
45,721,160
|
|
||||
|
Earnings (loss) per share—diluted:
|
|
|
|
|
|
|
|
|
||||||||
|
Net income (loss) per share
|
|
$
|
0.15
|
|
|
$
|
0.32
|
|
|
$
|
0.29
|
|
|
$
|
(0.09
|
)
|
|
Weighted average shares—diluted
|
|
45,908,958
|
|
|
45,922,416
|
|
|
46,029,361
|
|
|
45,721,160
|
|
||||
|
2.1(p)
|
|
|
3.1(d)
|
|
|
3.2(i)
|
|
|
4.1(u)
|
|
|
10.1(a)
|
|
|
10.2(c)
|
|
|
10.3(e)
|
|
|
10.4(b)
|
|
|
10.5(m)
|
|
|
10.6(o)
|
|
|
10.7(p)
|
|
|
10.8(s)
|
|
|
10.9(s)
|
|
|
10.10(u)
|
|
|
10.11(h)
|
|
|
10.12(f)
|
|
|
10.13(g)
|
|
|
10.14(j)
|
|
|
10.15(k)
|
|
|
10.16(t)
|
|
|
10.17(l)
|
|
|
10.18(q)
|
|
|
10.19(q)
|
|
|
10.20(q)
|
|
|
10.21(q)
|
|
|
10.22(q)
|
|
|
10.23(q)
|
|
|
10.24(r)
|
|
|
10.25(s)
|
|
|
10.26(s)
|
|
|
10.27(v)
|
|
|
10.28(v)
|
|
|
10.29(v)
|
|
|
10.30(n)
|
|
|
10.31(p)
|
|
|
10.32(p)
|
|
|
10.33(r)
|
|
|
21.1
|
|
|
23.1
|
|
|
31.1
|
|
|
31.2
|
|
|
32.1
|
|
|
32.2
|
|
|
101.INS
|
XBRL Instance Document.
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document.
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
(a)
|
|
Incorporated by reference to the Exhibits filed with our Registration Statement on Form S-4 filed on October 4, 2002 (File No. 333-100351).
|
|
(b)
|
|
Incorporated by reference to the Exhibits filed with our Registration Statement on Form S-4 filed June 9, 2003 (File No. 333-105950).
|
|
(c)
|
|
Incorporated by reference to the Exhibits filed with Amendment No. 1 to our Registration Statement on Form S-1 filed on September 19, 2006 (File No. 333-136263).
|
|
(d)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on August 3, 2007 (File No. 001-10716).
|
|
(e)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on August 7, 2008 (File No. 001-10716).
|
|
(f)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on March 6, 2009 (File No. 001-10716).
|
|
(g)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on December 10, 2009 (File No. 001-10716).
|
|
(h)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on March 26, 2010 (File No. 001-10716).
|
|
(i)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on December 18, 2015 (File No. 001-10716).
|
|
(j)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on April 4, 2011 (File No. 001-10716).
|
|
(k)
|
|
Incorporated by reference to Appendix A filed with our Definitive Proxy Statement on Schedule 14A filed on April 5, 2013 (File No. 001-10716).
|
|
(l)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on August 23, 2013 (File No. 001-10716).
|
|
(m)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on October 21, 2013 (File No. 001-10716).
|
|
(n)
|
|
Incorporated by reference to the Exhibits filed with our Report on Form 8-K filed on November 13, 2013 (File No. 001-10716).
|
|
(o)
|
|
Incorporated by reference to the Exhibits filed with our Current Report on Form 8-K filed on October 20, 2014 (File No. 001-10716).
|
|
(p)
|
|
Incorporated by reference to the Exhibits filed with our Current Report on Form 8-K filed on July 6, 2015 (File No. 001-10716).
|
|
(q)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on April 28, 2016 (File No. 001-10716).
|
|
(r)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on October 27, 2016 (File No. 001-10716).
|
|
(s)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on April 27, 2017 (File No. 001-10716).
|
|
(t)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on July 27, 2017 (File No. 001-10716).
|
|
(u)
|
|
Incorporated by reference to the Exhibits filed with our Current Report on Form 8-K filed on September 20, 2017 (File No. 001-10716).
|
|
(v)
|
|
Incorporated by reference to the Exhibits filed with our Quarterly Report on Form 10-Q filed on August 7, 2018 (File No. 001-10716).
|
|
|
|
|
TRIMAS CORPORATION
(Registrant)
|
||
|
|
|
|
|
|
|
|
|
|
|
BY:
|
|
/s/ THOMAS A. AMATO
|
|
DATE:
|
February 28, 2019
|
|
|
|
Name: Thomas A. Amato
Title:
President and Chief Executive Officer
|
|
Name
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ THOMAS A. AMATO
|
|
President and Chief Executive Officer
|
|
February 28, 2019
|
|
Thomas A. Amato
|
|
(Principal Executive Officer) and Director
|
|
|
|
|
|
|
|
|
|
/s/ ROBERT J. ZALUPSKI
|
|
Chief Financial Officer
|
|
February 28, 2019
|
|
Robert J. Zalupski
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
|
|
/s/ PAUL A. SWART
|
|
Vice President Business Planning, Controller and Chief Accounting Officer
|
|
February 28, 2019
|
|
Paul A. Swart
|
|
(Principal Accounting Officer)
|
|
|
|
|
|
|
|
|
|
/s/ SAMUEL VALENTI III
|
|
Chairman of the Board of Directors
|
|
February 28, 2019
|
|
Samuel Valenti III
|
|
|
|
|
|
|
|
|
|
|
|
/s/ RICHARD M. GABRYS
|
|
Director
|
|
February 28, 2019
|
|
Richard M. Gabrys
|
|
|
|
|
|
|
|
|
|
|
|
/s/ NANCY S. GOUGARTY
|
|
Director
|
|
February 28, 2019
|
|
Nancy S. Gougarty
|
|
|
|
|
|
|
|
|
|
|
|
/s/ JEFFREY M. GREENE
|
|
Director
|
|
February 28, 2019
|
|
Jeffrey M. Greene
|
|
|
|
|
|
|
|
|
|
|
|
/s/ EUGENE A. MILLER
|
|
Director
|
|
February 28, 2019
|
|
Eugene A. Miller
|
|
|
|
|
|
|
|
|
|
|
|
/s/ HERBERT K. PARKER
|
|
Director
|
|
February 28, 2019
|
|
Herbert K. Parker
|
|
|
|
|
|
|
|
|
|
|
|
/s/ NICK L. STANAGE
|
|
Director
|
|
February 28, 2019
|
|
Nick L. Stanage
|
|
|
|
|
|
|
|
|
|
|
|
/s/ DANIEL P. TREDWELL
|
|
Director
|
|
February 28, 2019
|
|
Daniel P. Tredwell
|
|
|
|
|
|
|
|
|
|
ADDITIONS
|
|
|
|
|
||||||||||||
|
DESCRIPTION
|
|
BALANCE
AT
BEGINNING
OF PERIOD
|
|
CHARGED
TO
COSTS AND
EXPENSES
|
|
CHARGED
(CREDITED)
TO OTHER
ACCOUNTS
|
|
DEDUCTIONS
(A)
|
|
BALANCE
AT END
OF PERIOD
|
||||||||||
|
Allowance for doubtful accounts deducted from accounts receivable in the balance sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Year ended December 31, 2018
|
|
$
|
4,130,000
|
|
|
$
|
1,640,000
|
|
|
$
|
170,000
|
|
|
$
|
2,550,000
|
|
|
$
|
3,390,000
|
|
|
Year ended December 31, 2017
|
|
$
|
4,580,000
|
|
|
$
|
2,730,000
|
|
|
$
|
(140,000
|
)
|
|
$
|
3,040,000
|
|
|
$
|
4,130,000
|
|
|
Year ended December 31, 2016
|
|
$
|
3,710,000
|
|
|
$
|
2,770,000
|
|
|
$
|
(90,000
|
)
|
|
$
|
1,810,000
|
|
|
$
|
4,580,000
|
|
|
(A)
|
Deductions, representing uncollectible accounts written-off, less recoveries of amounts reserved in prior years.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|